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 The lateral line is a sensory system that aquatic organisms use to sense local water 
currents in their environment using mechanosensory neuromasts. It makes for an excellent 
model system in which to study cell signaling and collective cell migration, given its 
superficial location just beneath the epidermis, and the variety of genetic tools available in 
zebrafish. Development of the posterior lateral line is spearheaded by the posterior lateral 
line primordium (PLLP), which is a group of about 120 cells that collectively migrate from 
the ear to the tip of the tail between 24 and 48hpf. As it migrates, the PLLP periodically 
deposits sensory organs from its trailing end. Two signaling systems play important roles 
in patterning the cells of the PLLP, working in concert to assemble protoneuromasts and 
mediate migration. Wnt signaling maintains a population of largely mesenchymal cells in 
the leading domain, and also initiates transcription of two Fgf ligands, while repressing the 
Fgf receptor. The Fgf ligands are delivered to trailing cells, where they activate their 
receptor and downstream signaling induces epithelialization and protoneuromasts 
formation. Fgf also acts as a migrational cue for trailing cells to follow the leading 
migratory cells. 
 Heparan sulfate proteoglycans (HSPGs), embedded in the cell membrane and 
distributed throughout the extracellular matrix, are known to widely regulate signaling 
pathways, including Wnt and Fgf signaling. HSPGs are composed of a core protein with 
covalently linked heparan sulfate chains, which are heavily modified by a series of 
enzymes during synthesis. I examined the role of Syndecan4 (Sdc4), a type of core protein 
and 3-O-sulfation, a rare modification made to heparan sulfate, in regulating signaling of 
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the PLLP. My findings indicate that both Sdc4 and 3-O-sulfation promote Fgf signaling 
and the downstream processes of protoneuromast formation and cell migration. 
 I demonstrate that sdc4 is expressed in the trailing domain of the PLLP, where it is 
negatively regulated by Fgf signaling. Morpholino-mediated knockdown of sdc4 interferes 
with protoneuromast formation and significantly slows the speed of migration, both of 
which most likely result from weak Fgf signaling. In sdc4 mutants, I also show that Fgf 
signaling is compromised. Sdc4 mutants are more vulnerable to manipulation of Fgf 
signaling, exhibiting decreased migration speed when treated with low doses of various 
inhibitors of Fgf. In addition to their susceptibility to Fgf signaling inhibition, sdc4 mutant 
PLLP migration is slower after sdc3 knockdown. 
 In addition to the importance of particular core proteins, I show that specific 
modifications to the heparan sulfate chain also support Fgf signaling. Two 3-O-
sulfotransferases, hs3st3b1a and hs3st3b1b, are expressed in the leading domain of the 
PLLP. Wnt signaling activates expression of both genes, and Fgf is a co-activator of 
hs3st3b1b. Knockdown of hs3st3b1a causes a decrease in Fgf signaling and impaired 
protoneuromast formation. Hs3st3b1a/hs3st3b1b double mutants show a similar 
phenotype, with a decrease in the number of neuromasts deposited by the PLLP.  
 The sum of these results suggests a regulatory mechanism for Fgf signaling in 
which core syndecan proteins and 3-O-sulfation modifications are both active. Hs3st3b1a 
and Hs3st3b1b are present in the leading domain, where Fgf signaling is not typically 
active, due to repression of the Fgf receptor. However, leading cells do produce the Fgf3 
and Fgf10 ligands, which activate FgfR1, present on trailing cells. Given the evidence that 
Hs3st3s regulate Fgf signaling, it seems plausible that they play some role in the effective 
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delivery of the Fgf ligands to trailing cells. Meanwhile, Sdc4 is present on trailing cells, 
and regulates reception of the Fgf ligands, possibly as an independent receptor or as a co-
receptor to FgfR1. Thus, Sdc4, and 3-O-sulfated HSPGs cooperate to support Fgf signaling 
and the downstream processes of protoneuromast assembly and collective cell migration. 
 
Thesis advisor/reader: Ajay Chitnis, MD, PhD 
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Chapter 1: Introduction 
1.1 The posterior lateral line of zebrafish 
 Aquatic vertebrates have a “distant-touch” sense mediated by the lateral line 
system. The lateral line is composed of a network of organs across the body surface, where 
their superficial location allows them to sense water flow in the animal’s immediate 
environment. These organs are sensitive to pressure and vibration, allowing the animal to 
detect changes in local water currents. This sense informs the animal’s spacial awareness 
and facilitates behaviors such as schooling, mating, prey detection, and predator avoidance 
[2]. For example, fish can use information gathered by their lateral lines to follow the wake 
of swimming prey [3] or orient themselves towards water currents [4]. 
 The organs of the lateral line are mechanosensory neuromasts, which are distributed 
in a stereotypical pattern across the surface of the animal. Neuromasts are composed of 
peripheral support cells and central hair cells that function much like the hair cells of the 
mammalian inner ear. The hair cells extend a ciliary bundle through the epidermis, out into 
the surrounding water, shielded by a jelly-like cupula. Water currents displace ciliary 
bundles, and when each hair cell is displaced in a specific direction, it increases its firing 
rate to communicate information about the directional movement of water to the central 
nervous system. 
 In zebrafish (Danio rerio), the lateral line is subdivided into the head neuromasts 
that make up the anterior lateral line (ALL) and the trunk neuromasts of the posterior lateral 
line (PLL). The posterior lateral line primordium (PLLP) spearheads the early development 
of this system, establishing the first neuromasts along the horizontal myoseptum. The 
PLLP is a group of approximately 125 cells that forms just posterior to the otic vesicle. At 
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about 22 hours post fertilization (hpf), the cells of the PLLP detach from the lateral line 
placode and collectively migrate along the horizontal myoseptum just under the skin, 
finally reaching the tip of the tail at 48hpf (Figure 1.1.1). As migration progresses, trailing 
cells within the PLLP organize into rosette-shaped protoneuromasts that are then deposited 
from the trailing end. In general, about six neuromasts are deposited, plus a terminal cluster 
of two or three neuromasts, deposited where the PLLP fragments when migration 
terminates at the tail tip. While the PLLP establishes the first neuromasts of the lateral line, 
there will ultimately be many more. Additional neuromasts arise via three different 
mechanisms: 1) interneuromast cells, which are also deposited by the PLLP, are latent 
precursors that will later proliferate and form neuromasts [5]; 2) after the PLLP, two more 
primordia migrate and deposit neuromasts along the horizontal myoseptum and the dorsal 
midline, each primordium developing from different placodes and with their own 
innervating ganglia [6]; and 3) budding from existing neuromasts [7]. 
 
Figure 1.1.1: As the PLLP migrates, 
neuromasts are deposited from the trailing 
edge. The posterior lateral line primordium 
(PLLP) migrates along the horizontal 
myoseptum between 22 and 48hpf. As it 
progresses, neuromasts are periodically 
deposited (L1, L2, etc.), ultimately 
depositing 6 or 7 neuromasts, plus a terminal 
cluster. Migration slows at the PLLP reaches 
the tip of the tail. The PLLP terminates once 
it reaches the tail tip and fragments into a 
cluster of terminal neuromasts (TN). Adapted 
from Chitnis and Nogare, Principles of 
Developmental Genetics, 2015 [1]. 
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1.2 Cell-cell signaling in the posterior lateral line primordium 
Wnt and Fgf signaling 
 Within the PLLP, two signaling networks work in concert to pattern the cells of the 
leading and trailing domains (Figure 1.2.1A and B). The leading domain is characterized 
by relatively high levels of Wnt signaling activity, which maintains a population of 
mesenchymal-like cells [8]. Wnt tapers off towards the trailing end, where Fgf signaling 
organizes cells into epithelial rosettes that are eventually deposited as neuromasts [9, 10]. 
Fgf signaling induces cells to adopt a more columnar, epithelial morphology and promotes 
actin to associate with apical junctions, thereby inducing apical constriction. The domain 
of Wnt activity is essential for establishing the Fgf signaling center in the adjacent trailing 
domain. Initially, Wnt stimulates signaling throughout much of the PLLP, which then 
activates transcription of the ligands Fgf3 and Fgf10a (Figure 1.2.1C). Simultaneously, 
Wnt activates expression of sef, the FgfR1 inhibitor, and Fgf signaling cannot be activated 
where Wnt is strongest [11]. The Fgf ligands thus bind FgfR1 and activate downstream 
signaling in the most trailing cells of the PLLP, where Wnt signaling abates. In turn, Fgf 
signaling activates expression of the Wnt inhibitor dikkopf (dkk1b). The balance of the Wnt 
and Fgf signaling domains is further regulated by dusp6, an inhibitor of intracellular ERK 
signaling [12]. Dusp6 is expressed in the leading two-thirds of the PLLP, dually activated 
by Wnt in leading cells and Fgf in more trailing cells, and inhibits Fgf-dependent 
incorporation of cells into protoneuromasts. Thus, this mutually inhibitory feedback system 
restricts Wnt activity to the leading domain and Fgf activity to the trailing domain. Broad 
Fgf signaling activity abates in the most trailing cells of the PLLP, as they are located 
furthest from the leading zone and, thus, from the source of Fgf3 and Fgf10a.  
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Figure 1.2.1: Wnt and Fgf work together signaling direct the mesenchymal to epithelial transition 
that forms protoneuromasts. (A) Cells in the leading domain are mesenchymal-like, while trailing cells 
are more epithelial in nature. The epithelial-like cells of the trailing domain organize into protoneuromasts. 
(B) Wnt signaling is dominant in the leading domain, where it maintains the population of mesenchymal-
like cells. In more trailing cells, Fgf directs the progressive epithelialization of cells and organizes them into 
protoneuromasts. Initiation of protoneuromast formation occurs as cells group together and mature as proper 
rosette formations form, with a hair cell progenitor at the center and peripheral cells organized around it. 
Neuromasts are deposited from the trailing end. (C) Initially, Wnt signaling is dominant throughout the 
PLLP. Wnt activity initiates transcription of two Fgf ligands, which establish Fgf signaling in the trailing 
domain. The Wnt and Fgf systems are mutually inhibitory resulting in the establishment of distinct domains 
in the leading and trailing zones, respectively. Adapted from Chitnis and Nogare, Principles of 
Developmental Genetics, 2015 [1]. 
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 Perturbation of either Wnt or Fgf signaling results in defects in PLLP migration or 
rosette morphogenesis. Both overactivation and inhibition of the Wnt system cause defects 
in migration. When Wnt signaling is constitutively active, as in apc mutants or under 
treatment with the GSK-3 inhibitor BIO, and when it is suppressed, by treatment with Wnt 
inhibitor IWR or in lef1 mutants, primordia stall before reaching the tip of the tail [8, 12-
14]. Manipulation of the Wnt system likely causes migration defects because Wnt signaling 
activates expression of cxcr4b, fgf3, and fgf10a [8]. When Wnt activity increases or 
decreases, downstream transcriptional targets will be upregulated or downregulated, and if 
those targets play central roles in the collective cell migration of the PLLP, migration is 
likely to be impacted. Alternatively, complete inhibition of the Fgf signaling system, as in 
Fgf3:Fgf10a double mutants or SU5402-treated embryos, results in slow migration, 
inhibition of protoneuromast assembly, and ultimately stalling [8-10]. Partial inhibition of 
the Fgf system, through injection of an fgf10a morpholino, results in normal migration, but 
causes a significant delay in protoneuromast formation and deposition [12].  
 In this way, the Wnt and Fgf signaling systems are critical determinants of when 
and where protoneuromasts form, as well as migration of the system as a whole. Wnt 
activity tapers from leading to trailing end, while Fgf signaling starts at some distance from 
the leading edge and also diminishes toward the trailing end, as cells are further removed 
from the leading source of Fgf ligand. There is, however, limited Fgf signaling maintained 





 Collective migration of the approximately 125 cells of the PLLP is steered by the 
chemokine signaling system. This system guides migration in a number of different cell 
types, including germ cells, leukocytes, neurons, and metastatic cancer cells [15]. The 
chemokine ligand Cxcl12a (formerly known as Sdf1a) initiates G protein-coupled 
signaling via interactions with the Cxcr4b chemokine receptor. This triggers an influx of 
calcium ions that promotes migratory behavior through regulation of protrusive activity 
and/or cell shape and adhesion [16, 17]. Meanwhile, binding of Cxcl12a to the Cxcr7b 
chemokine receptor does not initiate G protein-coupled signaling, and is therefore not 
generally thought to regulate cell migration [18]. 
The cxcl12a ligand is expressed in a uniform stripe along the horizontal myoseptum 
and two chemokine receptors are expressed in the PLLP [19-21] (Figure 1.2.2 A-E). Cells 
in the leading two-thirds of the primordium express the cxcl12a receptor cxcr4b, while the 
trailing cells express a different receptor, cxcr7b, and these receptors allow the PLLP to 
follow the trail of Cxcl12a. Disrupting Cxcl12a or either of its receptors inhibits migration 
of the PLLP [19, 21]. It is the polarized expression of these two receptors that allows the 
PLLP to dependably migrate from anterior to posterior, despite the uniform expression of 
cxcl12a. It is hypothesized that both Cxcr4b and Cxcr7b are internalized after binding their 
ligand, but only activated Cxcr4b is capable of initiating downstream signaling that induces 
migratory behavior [19, 22]. Meanwhile, after Cxcl12a binds to the Cxcr7b receptor, the 
complex is internalized, Cxcl12a is degraded, and Cxcr7b is recycled back to the cell 
surface, where it is available to bind new ligand [23]. The cxcr7b-expressing region 
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therefore acts as a sink for Cxcl12a, contributing to a local gradient of chemokine ligand  
along the length of the PLLP [24, 25]. Under these conditions, there is a high level of 
Cxcl12a available at the leading edge for Cxcr4b to bind, and decreased levels of ligand 
available to the more trailing cells. This ensures that the PLLP migrates preferentially 
Figure 1.2.2: Chemokine signaling guides directional migration of the PLLP, while Fgf is a 
migrational cue for trailing cells. (A) Schematic showing a whole-embryo view of PLLP migration. A 
uniform stripe of Cxcl12a ligand is located along the horizontal myoseptum. The PLLP follows this stripe 
of ligand, migrating from posterior to anterior. (B) The PLLP expresses two chemokine receptors, Cxcr4b 
in the leading domain and Cxcr7b in the trailing domain. (C) In situ hybridization showing cxcl12a 
expression along the horizontal myoseptum. (D, E) In situ hybridization shows expression of cxcr4b and 
cxcr7b in the leading and trailing domains, respectively. (F) Schematic showing how the differential 
expression of Cxcr4b and Cxcr7b allow the PLLP to generate a local gradient of Cxcl12a along the length 
of the primordium. This allows the PLLP to react to the relatively high levels of Cxcl12a available to 
leading cells, and consistently guide the PLLP in one direction for the duration of migration. (G) Wnt 
activates Fgf3 and Fgf10 in leading cells. Fgf ligands are delivered from leading cells to trailing cells, 
where they activate FgfR1. In response to Fgf signaling, trailing cells migrate, following the leading zone. 
Adapted from Chitnis and Nogare, Principles of Developmental Genetics, 2015 [1]. 
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towards the posterior end of the fish, as opposed to regressing anteriorly back to its starting 
point. 
 The chemokine signaling system guides PLLP migration primarily through the 
migratory behavior of the cells at the leading edge. However, fibroblast growth factor (Fgf) 
signaling is also important to this migration process, as suppression of Fgf activity causes 
the system to stall, halting migration [10]. Instead of responding directly to migration-
inducing chemokines, the more trailing cells of the PLLP actually play follow-the-leader 
and migrate in response to the Fgf cues produced by cells in the leading domain [26] 
(Figure 1.2.3G). In primordia severed by laser ablation, trailing cells migrate and rejoin 
leading cells. Migration of the severed trailing portion occurs in response to the Fgf signal 
received from the leading portion, and this phenomenon occurs independent of chemokine 
signaling. 
Notch signaling 
 In addition to its roles in rosettogenesis and migration, Fgf signaling is also 
responsible for the specification of a sensory hair cell progenitor at the center of each 
rosette. Fgf signaling activates expression of the proneural gene atoh1a, a basic helix-loop-
helix transcription factor, which gives PLLP cells the potential to become sensory hair cells 
[9] (Figure 1.2.3). Atoh1a is expressed in a center-biased pattern, and in the most trailing 
protoneuromasts, its expression is restricted to the central cell of the rosette [27]. In the 
central cells of the rosettes, two Notch ligands, deltaA and deltaD, are activated by Fgf 
signaling and Atoh1a, respectively. Meanwhile, undifferentiated cells and support cells 
express notch3 [28]. DeltaA and DeltaD can then activate Notch signaling in neighboring 
cells, which suppresses atoh1a expression in those cells [27]. When Notch signaling is lost, 
	 9	
as in mib1 mutants, atoh1a expression is unregulated and expanded, ultimately resulting in 
the loss of Fgf signaling, expansion of Wnt signaling, defective formation and maintenance 
of protoneuromasts, and stalling of PLLP migration. In the most trailing protoneuromast, 
Atoh1a also activates expression of its homolog, atoh1b, which, in turn, activates atoh1a. 
This positive feedback loop allows sustained expression of atoh1a specifically in the 
Figure 1.2.3: Notch and Fgf signaling specify the central cell of the rosette as a hair cell progenitor. 
(A) Wnt signaling in the leading domain activates expression of two Fgf ligands, Fgf3 and Fgf10. In turn, 
Fgf signaling activates center-biased expression of atoh1a in forming protoneuromasts. Atoh1a gives cells 
the potential to become sensory hair cells and becomes progressively more restricted to the central cell in 
the middle of each rosette. Atoh1a activates expression of fgf10, while also repressing fgfr1. Peripheral cells 
don’t repress fgfr1 and can respond to the Fgf10 ligand produced by the atoh1a-expressing cell. (B) 
Signaling schematic showing how Notch and Fgf signaling restrict atoh1a expression, ensuring that the 
central cell is specified as the hair cell progenitor. In the central cell (blue), a positive feedback loop between 
Atoh1a and Atoh1b ensures sustained expression of atoh1a. Atoh1a signaling also activates the Notch 
ligand DeltaD and Fgf10, while suppressing FgfR1. On neighboring peripheral cells (orange), DeltaD 
activates the Notch3 receptor, while Fgf10 (released by the central cell) activates FgfR1. Notch3 signaling 
suppresses Atoh1a, thereby allowing continued FgfR1 activity that supports notch3 expression. Adapted 
from Chitnis and Nogare, Principles of Developmental Genetics, 2015 [1]. 
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central hair cell progenitor. Atoh1a, once established in the central hair cell progenitor, 
subsequently establishes a new Fgf signaling center, as it activates expression of fgf10a 
and inhibits fgfr1. Neighboring cells, inhibited from expressing atoh1a by Notch signaling, 
can freely express fgfr1 and are capable of responding to the Fgf10a signal. Fgf signaling 
in these cells helps to maintain fgfr1 and notch3 expression, thereby suppressing the 
potential to be a sensory hair cell. Hence, a process of lateral inhibition ensures that the 
central cell is designated as the hair cell progenitor and neighboring cells are fated to be 
support cells. 
 Although terrestrial vertebrates do not have a distant-touch sense, the unique 
characteristics and accessibility of the zebrafish lateral line make it an extraordinarily 
tractable system in which to study several broadly applicable biological questions. The hair 
cells of the lateral line can regenerate after damage or death, and so this is an excellent 
system in which to studying the mechanisms driving damage and regeneration. 
Understanding the signaling networks and physical forces that regulate collective 
migration of the PLLP advances our general knowledge of collective cell migration, a 
process that is important in several different developmental contexts, as well as the 
metastasis of certain types of cancer. There are multiple signaling networks that pattern the 
PLLP and probing these networks contributes to our broader understanding of how these 
networks can coordinate cell fate decisions and morphogenesis during development. It is 
this last question of how intercellular signaling is regulated on which my project has 
focused. In particular, I am interested in how heparan sulfate proteoglycans (HSPGs) 
interact with signals among the cells of the PLLP, and how that interaction impacts 
morphogenesis of the PLL. By understanding the mechanisms that regulate HSPG 
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expression and function and how they, in turn, influence the dynamics of Wnt and Fgf 
signaling, we hope to develop a better understanding of the self-organization of the 
zebrafish posterior lateral line. 
 
1.3 Structure of heparan sulfate proteoglycans 
General structure and function 
 Heparan sulfate proteoglycans (HSPGs) are found on the cell surface, as well as 
distributed throughout the extracellular matrix, in most types of animal tissues. They 
emerged early in animal evolution, as they are present in nearly all animal species [29]. 
Due to the high variability of heparan sulfate (HS) structure and the structural specificity 
required by ligands, HSPGs are capable of regulating a wide variety molecular and cellular 
processes by expressing core proteins and modifying enzymes in a tissue-specific manner. 
Among their many functions, HSPGs are particularly well-studied in the context of cell-
cell signaling, including the Wnt and Fgf pathways (reviewed in [30]). As a result of their 
binding interactions with signaling ligands and receptors, HSPGs have many demonstrated 
roles, including those in pattern formation, cell adhesion, and cell migration (reviewed in 
[31, 32]). HSPGs are so critical to these processes that in several model organisms 
disruption of heparan sulfate biosynthesis can cause death during development [33, 34] and 
is known to cause the disorder hereditary multiple osteochondromas in humans. Given the 
particular roles for HSPGs in the signaling networks and functions that are central in PLL 
development, I am interested how they regulate signaling within the PLLP and how that 
impacts pattern formation in this developing system. 
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 HSPGs belong to a large family of proteoglycans, all of which are hybrid molecules 
composed of a core protein and covalently attached glycosaminoglycan (GAG) chains. 
GAG chains are linear polysaccharides modified by a series of enzymes during synthesis 
in the Golgi. There are four classes of GAGs: chondroitin sulfate, dermatan sulfate, heparan 
sulfate (HS), and keratan sulfate. Each class is differentiated by their saccharide subunit, 
level and type of sulfation, and epimerization. Among GAGs, HS is unique in that virtually 
all cell types express at least one HSPG core protein and the GAG chains of HSPGs have 
the most highly variable structure [35]. 
 The core proteins of HSPGs are believed to have limited functions of their own, but 
are of central importance to the localization of the molecule. There are three major types 
of HSPG core proteins: 1) Syndecans are transmembrane proteins usually found embedded 
in the cell membrane; 2) Glypicans are also found on the cell surface, attached via a GPI 
anchor; and 3) Extracellular Matrix (ECM) proteins such as perlecan, agrin, and collagen 
XVIII (Figure 1.3.1). Although syndecans and glypicans are typically associated with the 
cell membrane, both proteins have cleavage sites that allow for shedding of these HSPGs 
from the cell surface. Many cells express multiple types of core proteins, but the HS chains 
on different core proteins of the same cell generally have the same sulfation patterns [36], 
suggesting that HS-modifying enzymes in the Golgi do not target specific core proteins, 
instead modifying all HSGAGs equally.  
 
Core proteins in the zebrafish genome and their expression in the PLLP 
 The zebrafish genome contains three syndecan genes (sdc2, sdc3, and sdc4) [37], 
ten glypican genes (gpc1a, gpc1b, gpc2, gpc3, gpc4, gpc5a, gpc5b, gpc5c, gpc6a, and 
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gpc6b) [38], one perlecan (hspg2), one agrin (agrn), and one collagen XVIII (col18a1). Of 
these core proteins, six are specifically expressed in the PLLP. Sdc3 is expressed 
throughout the primordium, with slightly higher expression in the central cells [39]. Sdc4 
is expressed in the trailing domain, with the strongest expression in the next-to-be-
deposited protoneuromast and deposited neuromasts. Gpc1b is expressed in a few cells at 
the very leading edge of the PLLP and gpc4 is expressed in the trailing two-thirds of the 
PLLP. Agrn and gpc1a also show specific expression in the PLLP, but the exact domain of 
expression within the PLLP has yet to be defined [38, 40]. Given their distinct expression 
patterns, it seems likely that each core protein has a specific function. 
 
Figure 1.3.1: There are three classes of HSPG core proteins. Syndecan and Glypican are two HSPG core 
proteins that are associated with the cell membrane. Syndecans are transmembrane proteins, with a small 
intracellular domain and a large extracellular domain with several attached heparan sulfate chains. Glypicans 
are attached to the cell membrane via a GPI anchor and also have a large extracellular domain with multiple 
heparan sulfate chains. ECM proteins, which include perlecan, agrin, and collagen XVIII, exist in the 
extracellular space and associate with the ECM. The structure of each core protein is critical in determining 
its localization. 
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1.4 Biosynthesis of heparan sulfate glycosaminoglycan chains 
 The wide variety of HSPG functions is, in part, attributable to the variety of 
HSGAG chain structures, as these varied structures are each capable of specifically binding 
certain proteins whose function they modulate. The HSGAG chain backbone is composed 
of repeating disaccharide subunits of glucosamine and hexuronic acid (HexA). The 
hexuronic acid can be either D-glucuronic acid (GlcA) or its epimer L-iduronic acid 
(IdoA). Each subunit can be modified in a variety of ways. Glucosamine can be N-
acetylated (GlcNAc), N-sulfated (GlcNS), or O-sulfated at positions 3 and 6. O-sulfation 
can also occur at position 2 of the hexuronic acid. Synthesis is a stepwise process, and a 




 There are three stages of HSGAG chain synthesis: initiation, polymerization, and 
modification. Initiation of all four types of GAG chains begins with the attachment of a 
tetrasaccharide linker to specific serine residues in the core protein. Attachment sites 
always consist of a Ser-Gly dipeptide, and heparan sulfate assembly is enhanced if 
repetitive Ser-Gly sequences and clusters of acidic amino acids flank the attachment site 
[41, 42]. Xylosyltransferase selects the attachment site and transfers a xylose, then 
galactosyltransferases add two D-galactose units, and, finally, glucuronosyltranferase I 
adds a GlcA. This completes the tetrasaccharide linker and the final addition of α4GlcNAc 




Figure 1.4.1: Heparan sulfate glycosaminoglycan chains are synthesized in a step-wise manner by a 
series of enzymes. During initiation, enzymes build a tetrasaccharide linker on specific serine residues in the 
core protein. During polymerization, exostosins add alternating glucosamine (GlcNAc) and glucuronic acid 
(GlcA) subunits. Five enzyme families perform specific modifications along the GAG chain. NDSTs 
deacetylate and subsequently sulfate some GlcNac subunits. A C5-epimerase epimerizes GlcA into Iduronic 
Acid (IdoA). Hs2sts sulfate some IdoA subunits. Hs6sts and Hs3sts sulfate some GlcNAc and GlcNS 
residues. Each enzyme preferentially modifies particular residues, but none of them uniformly modify all 




 During polymerization of HS, the Exostosin (Ext) family of glycosyltransferases 
add alternating GlcA and GlcNAc to the growing end of the polysaccharide, ultimately 
producing GAG chains of variable length.  Zebrafish have four Ext genes, ext1a, ext1b, 
ext1c and ext2, and two Ext-like genes, extl2 and extl3. Exts are type II transmembrane 
proteins with a small N-terminal cytoplasmic domain, a single-pass transmembrane 
segment, a stem region, and a large C-terminal enzymatic domain containing two active 
sites [43]. Within the enzymatic domain, the most C-terminal site is likely responsible for 
GlcNAc transferase activity, while the active site located more towards the N-terminal is 
the GlcA transferase site. [44]. Mammalian Ext1 and Ext2 function as a complex, and this 
complex has higher enzymatic activity than either Ext alone [45]. Polymerization by Exts 
is traditionally thought to proceed in the absence of chain modification, however some 
studies suggest that these two processes occur simultaneously. GlcA is preferentially 
transferred to an acceptor with deacetylated, sulfated glucosamine (GlcNS) at its terminus 
[46]. GlcNS is generated by the activity of N-deacetylase/N-sulfotransferase (NDST), one 
of the modification enzymes, on GlcNAc. Furthermore, the addition of 3’-phosphoadenyl 
5’-phosphosulfate (PAPS), the sulfate donor from which sulfate groups are transferred to 
GAG subunits, stimulates polymerization of HS by Exts [47]. 
 
Modification 
 An epimerase and four classes of sulfotransferases perform modifications to the 
HSGAG chain. At each step, only some residues are modified, giving rise to the high 
diversity of HS structures and, therefore, the functional specificity and versatility of 
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HSPGs. First, NDSTs remove N-acetyl groups from some GlcNAc residues, nearly all of 
which are replaced with sulfate groups to produce GlcNS. In rare instances, deacetylated 
residues are left unsulfated, producing GlcNH2 [48]. GlcNS residues tend to occur in 
clusters, suggesting that once sulfation begins, NDSTs preferentially target those regions 
containing the first sulfation sites. While mammals have four NDST genes, Zebrafish have 
five: ndst1a, ndst1b, ndst2a, ndst2b, and ndst3 [49]. NDST structure is very similar to that 
of the glycosyltransferases: type II transmembrane protein with a large C-terminal domain 
containing catalytic sites for both N-deacetylation and N-sulfation [50, 51].  
 In the second step, D-glucuronyl-C5-epimerase (Glce) epimerizes GlcA to IdoA.  
Glce targets non-O-sulfated hexuronic acids located on the reducing side of non-O-sulfated 
GlcNS [52], thus ensuring that epimerization occurs after N-deacetylation/N-sulfation, but 
prior to O-sulfation. The zebrafish genome contains two of these epimerases, glcea and 
glceb, compared to just one in higher vertebrates [53].  The enzyme functions as a dimer 
with two catalytic sites in each of the C-terminal domains [54]. With epimerization, we 
begin to see how modification lends HS chains their specific functions, as epimerization 
serves to make HS chains more flexible and enables them to target specific ligands. 
Epimerization increases the flexibility of HS due to the fact that IdoA can adopt more 
conformations than either GlcA or GlcNAc [55], and in mouse embryonic fibroblasts, HS 
without IdoA was incapable of binding Fgf2 and glial-derived neurotrophic factor [56].  
 Third, uronosyl-2-O-sulfotransferase (Hs2st) sulfates position 2 on hexuronic acid 
residues. The enzyme preferably targets IdoA, stabilizing the epimer conformation, but the 
enzyme will also modify some GlcA subunits. The extent of 2-O-sulfation varies widely, 
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ranging from 50 to 90% of IdoA residues [57]. While other vertebrates have one Hs2st, 
zebrafish have two, hs2st1a and hs2st1b.  
 Fourth, some GlcNS and GlcNAc residues are sulfated at position 6 by 
glucosaminyl 6-O-sulfotransferase (Hs6st). While most other vertebrates have three 
Hs6sts, the zebrafish genome contains five Hs6st genes: hs6st1a, hs6st1b, hs6st2, hs6st3a, 
and hs6st3b. Each isoform of Hs6st appears to have its own specificity, but as a group these 
enzymes target IdoA-GlcNAc, HexA-GlcNS, and HexA-GlcNS3S for 6-O-sulfation [58]. 
Like NDST and Ext, Hs6st is a type II transmembrane protein with a C-terminal catalytic 
domain [59]. 
 The last modification made to the HS chain is the sulfation of GlcNS and GlcNAc 
residues at position 3 by glucosaminyl 3-O-sulfotransferase (Hs3st). This is a relatively 
rare modification, accounting for less than 1% of sulfation events along a given GAG chain 
[60, 61]. Although this modification is made infrequently, most vertebrates express seven 
3-O-sulfotransferases and zebrafish have eight Hs3st genes: hs3st1, hs3st1l1, hs3st1l2, 
hs3st2, hs3st3b1a, hs3st3b1b, hs3st3l, and hs3st4. Each hs3st has its own specific 
expression pattern and preferred target residues, suggesting regulatory and functional 
divergence [62].  
 
1.5 Regulation of cell-cell signaling by heparan sulfate proteoglycans 
 Among their many functions, HSPGs have recently been shown to positively 
regulate Fgf signaling in the migrating PLLP. The Piotrowski lab used ext2/extl3 double 
mutants, which are deficient in HSGAG chain synthesis, to examine the role of HS in the 
PLL [39]. They demonstrated that Fgf signal transduction relies upon functional HSPGs 
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and that HSPGs are critical for cell polarity in the PLLP. This is not an especially surprising 
discovery, given that HSPGs have long been known to regulate Fgf signaling in a number 
of different contexts. Several studies show that although Fgfs can bind the FgfR and 
activate downstream signaling, this interaction is more stable and prolonged in the presence 
of HSPGs [63-65]. FgfRs and paracrine Fgfs have HS-binding domains and generally have 
moderate-to-high affinity for HS [66, 67]. Small changes in the HS-binding domains allow 
Fgfs and FgfRs to selectively bind to specific HS chain sequences, meaning that different 
HSPGs elicit different downstream signaling responses [68]. For example, during 
branching morphogenesis in mouse lacrimal and salivary gland epithelium buds, Fgf7 and 
Fgf10 have different affinities for HS, and therefore induce different morphogenic effects. 
Fgf10 binds HS more strongly and promotes elongation, while Fgf7 binds HS less strongly 
and induces branching.  By reducing the binding strength of Fgf10 to HS, it becomes a 
functional mimic of Fgf7 [69]. Ext2 and extl3 mutants were previously shown to exhibit 
defective pectoral fin development, very similar to the defect seen in fgf10 mutants. 
Although Fgf10 protein is capable of rescuing this defect in fgf10 mutants, this is not true 
in ext2 or extl3 mutants, indicating that HSPGs are required for Fgf10 signaling during 
limb development in zebrafish. Meanwhile, Fgf4 is perfectly capable of activating 
downstream signaling in ext2 and extl3 mutants, indicating that the requirement for HS in 
the limb bud is specific to Fgf10 [70]. Overall, HSPGs are widely known to regulate Fgf 
signaling in a number of ways, including the restriction or facilitation of ligand diffusion, 
transportation of ligands to target cells, presentation of ligands to receptors, and 
stabilization of the ligand-receptor complex as co-receptors [66, 71].  
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 Although HSPGs’ signaling function is most well-studied in the context of Fgf 
signaling, they are known to regulate other signaling pathways, as well. In cell culture 
using mouse L cells, the presence of intact HSPGs stabilizes Wnt3a signaling [72]. 
Multiple Drosophila mutants with defective HSPG synthesis strongly resemble the Wnt 
mutant wingless phenotype and exhibit defective Wnt signaling [73-76]. In Gpc3 knockout 
mice, the non-canonical Wnt/JNK signaling pathway is inhibited, while the canonical 
Wnt/β-catenin signaling pathway is ectopically activated [77]. In Xenopus, Sdc4 has also 
been implicated in non-canonical Wnt signaling during convergent extension, as a binding 
partner of the Wnt receptor Frizzeled7 [78]. Notum is a secreted α/β-hydrolase that cleaves 
membrane-anchored glypicans from the cell surface. In both Drosophila and zebrafish 
Notum mutants, Wnt/β-catenin signaling is unrestricted, suggesting that glypicans shape 
the Wnt morphogen gradient [79, 80].  
 Recently, several studies have demonstrated the HSPGs may also regulate Notch 
signaling. In adults, skeletal muscle growth and repair depend on muscle cell progenitors 
that are maintained in a stem cell niche. Sdc3 and Notch are both components of this niche 
and without Sdc3, the cell cycle arrests in S phase. Sdc3 and Notch actually exist as a 
complex on the stem cell membrane and the Sdc3 mutant phenotype is rescued by ectopic 
expression of a constitutively active Notch intracellular domain [81]. In smooth muscle 
cells, Notch2 and Notch3 signaling activate sdc2 expression, and Sdc2 subsequently 
interacts with Notch3 to activate downstream signaling [82]. While HSPG core proteins 
appear to be important for Notch signaling in some contexts, the fine modifications on the 
GAG chains may be of less importance for Notch signaling, as 3-O-sulfation does not 
appear to be critical to Notch signaling in Drosophila. Both Drosophila 3-O-
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sulfotransferases, Hs3st-A and Hs3st-B, are involved in the regulation of intestinal stem 
cell proliferation and midgut homeostasis maintenance, but neither mutations in hs3st-b, 
nor RNAi knockdown of hs3st-a, induce defects in Notch signaling [83]. HSPGs’ potential 
to regulate Wnt, Fgf and, and Notch signaling is particularly interesting, given the 
importance of these three signaling pathways in patterning the PLLP. The questions that 
instigated the work presented in this dissertation center around which PLLP signaling 
pathways require HSPGs and how HSPGs impact the functions of those signaling 
networks. 
 One focus of this dissertation is Sdc4, which is very specifically expressed in the 
trailing domain of the PLLP. Sdc4 is a core protein that is known to interact with various 
growth factors and activate downstream signaling, including the Fgf signaling pathway. 
While the HS chains attached to the extracellular portion of the protein bind a variety of 
signaling ligands and receptors, the small intracellular domain has been shown to facilitate 
downstream signaling. Of particular interest to the study of PLLP signaling, Sdc4 has been 
shown to regulate both Fgf signaling (reviewed in [84]) and chemokine signaling ([85-88]). 
 Another focus of this dissertation is Hs3st, the enzyme that makes the final 
modification to the HSGAG chain. Two Hs3st enzymes are specifically expressed in the 
leading zone of the PLLP. Although few studies have focused on particular functions for 
3-O-sulfated HS, a number of binding partners have been identified (reviewed in [89]). 
Most notably, a recent study showed that 3-O-sulfation is critical in a binding interaction 
with FgfR and promotes signaling by Fgf10 [90]. 
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1.6 Aims of this thesis 
 Morphogenesis of the PLLP is dependent on the interplay between the Wnt and Fgf 
signaling pathways and the work in this thesis aims to increase our understanding of how 
these pathways are regulated to produce the zebrafish lateral line. Specifically, I am 
interested in how specific elements of HSPGs contribute to the regulation of cell signaling, 
the downstream functions of signaling pathways, and, ultimately, morphogenesis of the 
PLL. It was previously known that HSPGs are generally significant for PLL development 
and through the use of mutants and morphants, I have more specifically defined the 
functions of Sdc4, an HSPG core protein, and 3-O-sulfation, a unique HSPG modification. 
I initially focused on these two factors because the relevant proteins are specifically 
expressed in the PLLP. My work shows that both Sdc4 and 3-O-sulfated HSPGs are 
integrated into the signaling network of the PLLP, as each is regulated by PLLP signaling 
factors and each is also responsible for regulating that same signaling network. It is hoped 
that these studies provide additional insight into PLL development and, more generally, an 
improved comprehension of the regulation of intercellular signaling. 
 In chapter 2, I present work examining the roles of Sdc4 in Fgf signaling, especially 
migration of the PLLP. I show that Sdc4 is involved in protoneuromast formation and 
collective cell migration through promotion of Fgf signaling. Meanwhile, Fgf signaling 
regulates sdc4 by suppressing its expression, thereby establishing a negative feedback loop 
to moderate its own function. Lastly, I also demonstrate that Sdc3 can also support Fgf-
mediated functions, in addition to Sdc4. 
 In chapter 3, I explore the regulation and function of 3-O-sulfation, a very specific 
modification made to the HSGAG chain. I show that Wnt signaling mediates 
	 23	
transcriptional activation of two 3-O-sulfotransferases, thereby promoting this particular 
type of sulfation. Despite the fact that Fgf activity and 3-O-sulfated HS occupy distinct 
domains within the PLLP, 3-O-sulfation regulates protoneuromast formation via Fgf 
signaling. The co-expression of 3-O-sulfotransferases and Fgf ligands in the leading 
domain suggests that 3-O-sulfation of HSPGs is involved in the delivery of the Fgf signal 
to trailing cells. 
 Ultimately, Sdc4 and 3-O-sulfated HSPGs regulate PLL development via 
complementary roles in Fgf signaling. Wnt signaling promotes 3-O-sulfation of HSPGs, 
which, in turn, supports the production and/or delivery of Fgf ligands from leading cells in 
the PLLP. Meanwhile, Sdc4 assists with the reception of the Fgf signal in trailing cells and 
exists in a negative feedback loop with Fgf activity. Thus, this HSPG modification and 
core protein have specific functions in regulating cell signaling in the context of the 
zebrafish lateral line. 
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Chapter 2: Syndecan4 mediates cell differentiation and migration via 
Fgf signaling in the zebrafish lateral line primordium  
2.1 Introduction 
 A number of signaling pathways regulate development of the zebrafish lateral line. 
Within the primordium, Wnt and Fgf signaling are critical to the formation of 
protoneuromasts and cell migration. Meanwhile, chemokine signaling guides the collective 
cell migration of the entire primordium. HSPGs, expressed throughout nearly all animal 
tissues, have been shown to regulate cell signaling pathways and their downstream 
functions in development. Although the full extent of how HSPGs regulate signaling is still 
being studied, the core protein Sdc4 has been shown to regulate both Fgf signaling and 
chemokine signaling. Furthermore, Sdc4 is expressed in the trailing cells of the 
primordium, suggesting that it may play some function within the PLLP. 
	
Syndecan4 structure, signaling capabilities, and function 
 Syndecans all contain a PDZ-binding domain in their cytoplasmic tails that binds a 
number of ligands containing the PDZ motif. Sdc4 is unique among syndecans in that its 
cytoplasmic tail also has a seven-residue motif that binds phosphatidylinositol 4,5-
bisphosphate (PIP2) [91, 92]. The PDZ-binding domain is thought to facilitate the inclusion 
of syndecans into larger complexes, while PIP2 is hydrolyzed by phospholipase Cγ to 
produce two second messengers: 1) inositol 1,4,5-triphosphate, involved in the release of 
Ca2+ from the smooth endoplasmic reticulum; and 2) diacylglycerol, which activates 
protein kinase C alpha (PKCα). PKCα is involved in numerous signaling pathways and 
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cellular functions, including proliferation, differentiation and motility [93]. The PDZ- and 
PIP2-binding domains appear to regulate much of the downstream signaling effects of 
Sdc4. 
 Activation of Sdc4 has been shown to promote cell migration. The Rho GTPase 
family, which includes RhoG, Rac1, and RhoA, are involved in remodeling of the actin 
cytoskeleton [94]. When no external ligand is bound to Sdc4, Sdc4 binds synectin via the 
PDZ-binding domain and this interaction suppresses cell migration by inhibiting the 
activity of Rho GTPases [95, 96]. The binding of several external ligands, including Fgf2 
and the ECM component fibronectin, causes Sdc4 molecules to cluster into lipid rafts [97, 
98]. This clustering activates PKCα, releases the Rho GTPases to be activated, and 
ultimately promotes cell motility [99]. Sdc4 is also known to facilitate focal adhesion 
formation, a critical process during cell migration, in cooperation with integrin via 
interaction with fibronectin in the ECM [100, 101]. 
 
Syndecan4 as a regulator of Fgf signaling 
 Sdc4 has a well-documented history of regulating Fgf signaling, especially Fgf2. 
Both in cell culture and in vivo, the presence of Sdc4 enhances Fgf2 signaling and 
downstream responses such as migration and proliferation [102, 103]. This activation of 
Fgf signaling requires both the HS chains and the cytoplasmic tail of Sdc4. In sdc4-/- mouse 
muscle progenitor cells, Sdc3 cannot compensate for the loss of Sdc4, leading to near-total 
loss of Fgf2-induced ERK1/2 activation and a decrease in cell migration [104]. In rat 
endothelial cells, both the PIP2- and PDZ-binding domains are critical to Fgf2 signaling, 
but not for other growth factor signaling, suggesting that Sdc4 can selectively regulate Fgf 
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signaling through its cytoplasmic tail [105]. The interaction of Fgf2 and Sdc4 also 
determines the duration and intensity of Fgf-induced MAPK signaling [71]. In the absence 
of Fgf2, Sdc4 suppresses RhoG. When Fgf2 is introduced, an FgfR1-Sdc4-Fgf2 signaling 
complex is formed, releasing RhoG, which induces membrane ruffling and internalization 
of the complex via macropinocytosis. This internalization results in the formation of an 
active signaling vesicle that stimulates ERK1/2 signaling. Even with a dominant-negative 
FgfR, Fgf2 can transiently activate ERK1/2 signaling and cell migration in cells expressing 
Sdc4, activities that were inhibited by the removal of HSGAG chains [106]. In addition to 
promoting the intensity of Fgf signaling at the cell surface, Sdc4 can also regulate the range 
of the Fgf signal when the Sdc4 ectodomain is shed from the cell surface. In xenopus, the 
serine protease xHtrA1 cleaves Sdc4 to produce a soluble Fgf-ectodomain complex that 
promotes long-range signaling of Fgf4 [107]. The role of proteases and ectodomain 
shedding remains unexplored in in the PLLP. 
 
Syndecan4 as a regulator of chemokine signaling 
 In addition to its roles in Fgf signaling, Sdc4 has also been implicated in 
Cxcl12a/Cxcr4 signaling in tumor cells. Sdc4, but not Sdc1 or Sdc2, forms a complex with 
Cxcl12a and Cxcr4 in HeLa cells, peripheral lymphocytes, and macrophages [88]. Sdc4 
can independently bind both Cxcr4 and Cxcl12a, but while Cxcl12a binds to Sdc4 in a 
HSGAG chain-dependent manner, the binding of Cxcr4 to Sdc4 is independent of the 
HSGAG chains [87]. This suggests that the Cxcl12a ligand binds to the extracellular 
HSGAG chains of Sdc4 and the receptor Cxcr4 associates directly with the core protein. 
Cxcl12a-activated p44/p42 MAPK and JNK/SAP kinase signaling requires Sdc4, but the 
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Cxcl12a-dependent Ca2+ mobilization is independent of Sdc4, indicating that Sdc4 is 
selectively required for particular functions of Cxcl12a signaling [87]. Cxcl12a/Cxcr4 
signaling also induces shedding of the Sdc4 ectodomain in HeLa cells, suggesting that Sdc4 
plays an additional role in chemokine signaling away from the originating cell [85]. When 
Sdc4 is suppressed by RNAi, Cxcl12a-induced HeLa cell invasion is strongly reduced [86]. 
Thus, Sdc4 mediates some downstream chemokine signaling and cell chemotaxis as a co-
receptor for Cxcl12a.  
 Sdc4 is specifically expressed in the trailing domain of the PLLP [39], but its role 
in PLLP morphogenesis was unknown. We set out to study whether Sdc4 had a role in any 
of these signaling pathways and their downstream impacts on lateral line development. We 
find that sdc4 is expressed in the trailing domain, where it is suppressed by Fgf signaling. 
Using morpholino-mediated knockdown and mutants generated by the CRISPR/Cas9 
system, we show that the loss of Sdc4 interferes with the polarized Wnt-Fgf signaling 
system. The absence of Sdc4 weakens Fgf signaling activity, allowing the domain of Wnt 
signaling to expand. This, in turn, impacts the processes downstream of Fgf signaling, 
interfering with protoneuromast formation and PLLP migration. Additionally, another 
Syndecan, Sdc3, may be able to compensate for the loss of Sdc4. These results indicate 
that activation of the Fgf receptor, protoneuromast formation, and PLLP migration all 




2.2 Results  
Sdc4 is expressed in the trailing domain of the PLLP and suppressed by Fgf 
signaling 
 To determine where sdc4 is expressed in the PLL, in situ hybridization was 
performed in 31hpf zebrafish embryos, when the primordium is about mid-way through 
migration. As previously described, Sdc4 is expressed in the trailing domain of the PLLP 
[39], as well as in deposited neuromasts (Figure 2.2.1A and B). Although sdc4 is expressed 
in the trailing zone where Fgf signaling is generally more active (as indicated by pea3 
expression), sdc4 is strongest in the most trailing cells with less pea3 expression (Figure 
2.2.1C). The domain of sdc4 expression remains relatively stable during the course of 
migration, although the intensity of expression diminishes somewhat over time (Figure 
2.2.1D-F).  
 The domain of sdc4 expression suggests several possibilities for how it is regulated. 
Given its exclusion from the leading domain, it is possible that the Wnt and BMP signaling 
systems, both of which are active in the leading domain, suppress its expression. 
Figure 2.2.2: Sdc4 is expressed in the trailing domain of the primordium. (A) In situ hybridization for 
sdc4 shows expression in the trailing zone, especially in depositing neuromasts (arrowhead) (n=17). (B) 
Expression persists in deposited neuromasts (n=17). (C) Pea3, a marker of Fgf signaling activity, is also 
expressed in the trailing domain, although it is weaker in the most trailing cells (n=13). (D-F) A time course 
shows that the expression domain of sdc4 is relatively stable over eight hours, but the intensity of expression 
does decrease somewhat as migration progresses (26hpf n=20, 30hpf n=20, 34hpf n=20). All embryos used 
for in situ hybridization were derived from the transgenic line tg[cldnb:lynGFP], in which GFP is expressed  
in the PLLP. The dotted lines mark the outline of the PLLP, as delineated by a GFP antibody. 
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Furthermore, given expression of sdc4 in the trailing domain, within the domain of Fgf 
activity, it is possible that Fgf signaling activates expression of this HSPG. To investigate 
these possibilities, we used chemical inhibitors to manipulate these signaling pathways.  
 To investigate the possibility of Wnt as a leading zone suppressor, we used IWR to 
suppress Wnt signaling and BIO to activate Wnt signaling. IWR suppresses Wnt signaling 
by stabilizing Axin in the β-catenin destruction complex, thereby enabling the degradation 
of β-catenin, which mediates the canonical transcriptional response to Wnt signaling. BIO 
activates Wnt signaling through a complimentary mechanism, as it inhibits GSK-3 in the 
β-catenin destruction complex, allowing for a build-up of β-catenin and downstream 
transcriptional activation of Wnt targets. Lef1 expression demonstrates the efficacy of these 
two inhibitors (Figure 2.2.2E-G). Consistent with Wnt signaling also inhibiting sdc4 
expression, IWR increased and BIO somewhat suppressed sdc4 expression (Figure 2.2.2A-
Figure 3.2.2: Fgf signaling suppresses sdc4 expression. (A) DMSO controls show expression of sdc4 in 
trailing cells (n=17). (B) Suppression of Wnt signaling via IWR treatment also expands sdc4 expression 
(n=17). (C) BIO, which activates ectopic Wnt activity, has a small impact of sdc4 expression, subtly 
repressing it (n=20). (D) Treatment with K02288, an inhibitor of BMP signaling, also expands sdc4 
expression (n=18). (E,F,G) Lef1 in situ hybridization demonstrates the efficacy of IWR and BIO in regulating 
Wnt activity. IWR suppresses lef1 expression, while it expands under BIO treatment (DMSO n=16, IWR 
n=11, BIO n=16) (H,I,J) Inhibition of Fgf signaling through SU5402 or NaClO3 treatment expands sdc4 
expression, as compared to DMSO controls (DMSO n=17, SU5402 n=21, NaClO3 n=19). (K,L,M) Pea3 
expression show that SU5402 and NaClO3 treatments both suppress Fgf signaling (DMSO n=13, SU5402 
n=12, NaClO3 n=7).  
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C). Wnt activation also determines expression of bmp2b in the leading zone, so we asked 
if BMP signaling regulates sdc4 expression. Inhibition of BMP signaling with signaling 
inhibitor K02288 also increased sdc4 expression (Figure 2.2.2D), showing that this 
signaling pathway also has the potential to prevent sdc4 expression. These results indicate 
that Wnt signaling suppresses sdc4 expression in leading cells. 
 To determine if Fgf promotes expression of sdc4 in trailing cells, we inhibited Fgf 
signaling through treatment with the chemical inhibitors SU5402 and sodium chlorate 
(NaClO3), both of which suppress Fgf signaling as measured by pea3 expression (Figure 
2.2.2K-M). SU5402 suppresses Fgf signaling by directly inhibiting the FgfR, while 
NaClO3 indirectly inhibits Fgf by suppressing HSPG sulfation [39]. NaClO3 prevents the 
formation of the sulfation donor 3’-phosphoadenosin 5’-phosphosulfate (PAPS). The loss 
of PAPS prevents 2-O- and 6-O-sulfation [108], and sulfation is reduced by 55% [39]. This 
decrease in sulfation fundamentally changes HSPG structure, and diminishes their ability 
to bind targets. Fgfs and FgfRs are both HSPG binding partners, and this large-scale 
disruption in sulfation decreases the efficacy of Fgf signaling. Contrary to our hypothesis, 
both of these Fgf inhibitors expand sdc4 expression (Figure 2.2.2H-J). These observations 
raised the possibility that Fgf signaling actually suppresses sdc4 in nascent 
protoneuromasts located closer to the leading end, where Fgf signaling is more active, and 
that its expression is therefore only permitted in the most trailing protoneuromasts that are 
preparing for deposition, where Fgf signaling is lower (Figure 2.2.1A and C). It should also 
be noted that SU5402 and NaClO3 both inhibit Fgf signaling and permit more Wnt activity 
in the trailing zone, where Fgf signaling normally helps suppress Wnt signaling. However, 
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this indirect expansion in the domain of Wnt activity was not associated with reduced sdc4 
expression, suggesting that Wnt is probably not a direct suppressor of sdc4 expression.  
  While the effects of IWR and BIO suggest that Wnt suppresses sdc4 expression, 
inhibition of Fgf signaling, which is associated with an expansion of the domain of Wnt 
activity, caused  an expansion of sdc4 expression, rather than a reduction. This seemingly 
paradoxical observation suggested that changes in Fgf, Wnt, and BMP signaling might, in 
part, indirectly influence sdc4 signaling. Although IWR, BIO, NaClO3, and K02288 inhibit 
a variety of signaling pathways, they all slow or stall migration of the PLLP. Perhaps the 
inhibition of migration causes an upregulation in sdc4 expression. Consistent with this 
hypothesis, we observed an expansion of sdc4 expression in cxcl12a morphants, in which 
PLLP migration is arrested at the migration starting point (Figure 2.2.3A-C).  
 
Figure 2.2.3: Intensity of sdc4 expression is increased in cxcl12a morphants. (A,B) Representative 
images show the increase in expression in cxcl12a morphants, compared to WT controls. (C) Quantification 
of sdc4 expression in WT and cxcl12a morphants is significantly different (WT n=15, cxcl12aMO n=15).  
Expression intensity is normalized to background expression intensity, and is shown as a ratio of average 
PLLP pixel intensity to average background pixel intensity.  *p < 0.01. Bars represent mean ± SEM. 
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Knockdown of sdc4 interferes with protoneuromast formation and slows PLLP 
migration 
 Given the PLLP-specific expression of sdc4 in soon-to-be-deposited 
protoneuromasts, and the established importance for HSPGs in the PLLP [39], we 
examined the phenotype caused by morpholino knockdown of sdc4. A previously verified 
translation-blocking antisense morpholino [109], was used to target sdc4. We observed cell 
death in sdc4 morphant PLLP during time-lapse imaging, whereas WT PLLP experience 
little or no cell death.  Cell death is a known p53-dependent off-target effect of some 
morpholinos, and so in these preliminary studies examining the function of sdc4, we co-
injected a p53 morpholino to examine changes that were less likely to be determined by 
p53-dependent cell death. Sdc4 morphants have significantly fewer neuromasts and the 
primordium dissipates after depositing L4/L5, failing to migrate to the tip of the tail or 
deposit a terminal cluster (Figure 2.2.4A-C). In morphants, the first pair of neuromasts 
(L1/L2) is spaced further apart than wild-type, the next two pairs (L2/L3 and L3/L4) are 
Figure 2.2.4: Sdc4 morphants have fewer neuromasts. (A,B,C) Sdc4MO have significantly fewer 
neuromasts than uninjected embryos. The primordium dissipates after depositing L4/L5, failing to migrate 
to the tip of the tail or deposit a terminal cluster (WT n=20, sdc4MO=19). (D) Early neuromasts (L1 and L2) 
are spaced further apart, but become progressively more closely spaced. (E) Close spacing is due to a slow 
rate of migration, as confirmed by time-lapse microscopy (WT n=4, sdc4MO=5). *p < 0.01. Bars represent 
mean ± SEM. 
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normally spaced, and the final pair (L4/L5) is spaced significantly closer together than 
wild-type (Figure 2.2.4D).  Migration speed is reduced in sdc4 morphants, as measured in 
time-lapse movies that span from 28hpf to 48hpf (Figure 2.2.4E and Supplementary Movie 
1). The slow decline in the spacing between each subsequent pair of neuromasts is the 
result of slower migration. These results indicate that Sdc4 is important for normal 
migration of the PLLP.  
 The increased space between L1 and L2 suggested that protoneuromast formation 
may also be compromised in morphants. To determine if this was true, frames from time-
lapse movies were analyzed for neuromast number at five hourly intervals from 29hpf to 
33hpf. wild-type primordia generally had three protoneuromasts, while sdc4 morphants 
tended to have only two protoneuromasts (Figure 2.2.5A-C). Furthermore, NM1 and NM2 
were located further from the leading edge of the PLLP in morphants, relative to the length 
Figure 2.2.5: Sdc4 morphant primordia have fewer forming protoneuromasts. Frames from time-lapse 
movies were analyzed for neuromast number at five hourly intervals (29hpf-33hpf). (A,B,C) WT primordia 
have 3 protoneuromasts, while sdc4MO have only 2 protoneuromasts. Images show protoneuromasts (NM) 
in WT and sdc4MO, numbered and marked by arrows. Although sdc4MO primordia are shorter than WT 
primordia, they still had fewer neuromasts per unit of distance. (D) Each protoneuromast (generically marked 
as NM1 and NM2 because measurements were made over the course of five hours)  is located further from 
the leading edge of the PLLP in morphants, relative to the length of the primordium. (E,F,G,H) WT primordia 
show very clear protoneuromasts before, during, and after deposition; cells are arranged in the stereotypical 
rosette formation with clear apical constriction of the cells at the rosette center. (I,J,K,L) Although sdc4MO 
form and deposit protoneuromasts, their rosettes do not appear to be as clearly defined as in WT. Arrows 
mark neuromast centers. WT n=20, sdc4MO=25. *p < 0.05. Bars represent mean ± SEM. 
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of the primordium (Figure 2.2.5D). Although sdc4 morphant primordia are shorter than 
wild-type primordia, they still had fewer neuromasts when data was normalized to PLLP 
length. In addition to having fewer protoneuromasts at any given time, sdc4 morphant 
protoneuromasts are poorly formed. Wild-type primordia show very clear protoneuromasts 
before, during, and after deposition; cells are arranged in the stereotypical rosette formation 
with clear apical constriction of the cells at the rosette center (Figure 2.2.5E-H). Although 
morphants form and deposit protoneuromasts, their rosettes do not appear to be as clearly 
defined as wild-type rosettes, as determined in a transgenic line, which marks the 
boundaries of PLLP cells with GFP (tg[cldnb:lynGFP]; Figure 2.2.5I-L).  
 
Sdc4 morphants exhibit weak Fgf signaling 
 As knockdown of sdc4 hampered the timely and orderly formation of 
protoneuromasts, we examined pea3 expression in sdc4 morphants to determine if Fgf 
signaling, required for neuromast morphogenesis, is impaired. In morphants, pea3 
expression is less intense and the relative length of the expression domain is shorter (Figure 
2.2.6A-C). This indicates that Fgf signaling is weakened by the absence of Sdc4. 
Meanwhile, expression of lef1, a marker of Wnt activity, is expanded in the leading domain 
(Figure 2.2.6D-F). Since Fgf signaling normally represses Wnt activity, it may be that Wnt 
expands due to attenuated Fgf signaling caused by sdc4 knockdown.  
 
Ectopic expression of sdc4 causes dorsalization of zebrafish embryos 
 To this point, our results suggest that Sdc4 is required for Fgf signaling during 
PLLP migration and neuromast formation. In order to further investigate the function of 
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Sdc4, we ectopically expressed sdc4 by injecting sdc4 mRNA at the one-cell stage. At 
shield stage, embryos injected with 25pg of sdc4 mRNA showed increased expression of 
spry4, a target of Fgf signaling (Figure 2.2.7A and B). By the time body axis formation 
was complete, embryos injected with sdc4 mRNA have defects in dorsoventral axis 
patterning, where dorsal structures have developed at the expense of ventral structures 
(Figure 2.2.7C-G). This defect where the development of dorsal structures is favored over 
the development of ventral structures is known as dorsalization. Dorsalized embryos also 
exhibit some defects in anterior-posterior patterning. Imaged at 48hpf, even embryos 
injected with the low dose of 10pg of mRNA could be dorsalized, with about 17% of 
Figure 2.2.6: Sdc4 morphants exhibit weak Fgf signaling. (A,B) Pea3 expression is weaker in sdc4 
morphants (WT n=14, n=9). (C) The relative length of the pea3 domain is significantly reduced in sdc4MO. 
(D,E,F) Sdc4MO also have an expanded lef1 expression domain that is significantly longer, indicating that 
Wnt signaling is expanded (WT n = 12, sdc4MO=12).  *p < 0.01. Bars represent mean ± SEM. 
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embryos exhibiting a dorsalized phenotype. At 25pg and 50pg doses, 50% of embryos were 
dorsalized. Generally, the higher the dosage, the more severe the dorsalization. At dosages 
of 150pg and 300pg of sdc4 mRNA, all injected embryos were dorsalized (data not shown). 
During dorsoventral patterning, Fgf signaling allows for the development of dorsal 
structures, and ectopic activation of Fgf signaling can cause dorsalization [110, 111]. 
Therefore, dorsalization of sdc4 mRNA-injected embryos is consistent with our hypothesis 
that Sdc4 facilitates Fgf signaling in zebrafish. 
 Our results thus far indicate a role for Sdc4 in Fgf signaling, which is consistent 
with an extensive literature documenting the variety of functions Sdc4 plays in the Fgf 
signaling pathway. However, our results are based on morpholinos, which are known to 
have a number of off-target effects that can create false phenotypes [112, 113]. With 
regards to the lateral line specifically, we have found that morpholinos can cause expanded 
lef1 expression, reduced pea3 expression, and increased spacing between neuromasts as a 
result of their off-target effects, completely independent of the gene knockdown they 
Figure 2.2.7: Overexpression of sdc4 causes ectopic activation of Fgf signaling. (A) Expression of spry4, 
a target of Fgf signaling, is limited to the marginal zone at 50% epiboly (n=12). (B) Spry4 expression is 
increased in embryos injected with sdc4 mRNA (n=15). (C) Distribution of normal and dorsalized embryos 
in sdc4 mRNA-injected embryos (WT n=18, 10pg n=24, 25pg n=20, 50pg n=18). (D) Example of a WT 
embryos with a normal dorsoventral axis. (E,F,G) Examples of embryos, dorsalized to varying degrees, all 
injected with sdc4 mRNA. 
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perform. In order to demonstrate the validity of our morpholino-based findings, we 
generated targeted mutations in the extracellular domain of sdc4 using the CRISPR/Cas9 
system [114]. 
 
Sdc4 mutants have a normal pattern of neuromasts despite changes in signaling 
 Sdc4 mutants appear to have a normal number of neuromasts and the relative 
distance between neuromasts is similar to wild-type siblings (Figure 2.2.8 A- D). However, 
despite a normal pattern of neuromast deposition, the PLLP in sdc4 mutants does show 
some changes in Wnt and Fgf signaling. Expression of lef1 and pea3 was observed at three 
time points over eight hours during PLLP migration. At 26hpf, the intensity of lef1 
expression is similar between wild-types and mutants, but at 30hpf, lef1 expression is more 
intense in mutants (Figure 2.2.8E-J and Q). This indicates that Wnt signaling starts of 
relatively normal in sdc4 mutants, but it fails to regress at the same rate as it does in wild-
type embryos. Meanwhile, expression of pea3 appears normal at 26hpf, but by 30 and 
34hpf, its expression is significantly less intense in mutants (Figure 2.2.8K-P and R). This 
indicates that Fgf signaling, like Wnt signaling, is initially functioning at normal levels; as 
migration progresses, Fgf fails to maintain as high a level of activity as in wild-type. These 
results indicate that sdc4 is necessary for normal Wnt and Fgf signaling, but that the PLLP 
signaling network can still compensate for this loss, migrate, and establish a normal pattern 
of deposited neuromasts. 
 Because sdc4 morphants exhibit a slow speed of PLLP migration, we wanted to 
know if Sdc4 regulated PLLP migration through a role in chemokine signaling, in addition 
to its regulation of Fgf signaling. In cell culture experiments, Sdc4 has been shown to 
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Figure 2.2.8: Sdc4 mutants have a normal pattern of neuromast deposition, despite changes in Wnt 
and Fgf signaling. (A,B,C,D) The neuromast deposition pattern in sdc4 mutants is largely normal, with a 
normal number of neuromasts that are generally properly spaced (WT n=19, Δsdc4 n=14). (E,F,G,H,I,J, Q) 
In situ hybridization for lef1 in WT and mutants at 26hpf, 30hpf, and 34hpf (WT 26hpf n=15, WT 30hpf 
n=15, WT 34hpf n=15, Δsdc4 26hpf n=14, Δsdc4 30hpf n=19, Δsdc4 34hpf n=27). (K,L,M,N,O,P,R) In situ 
hybridization for pea3 in WT and mutants at 26hpf, 30hpf, and 34hpf(WT 26hpf n=14, WT 30hpf n=13, 
WT 34hpf n=15, Δsdc4 26hpf n=22, Δsdc4 30hpf n=20, Δsdc4 34hpf n=12). Expression intensity is 
normalized to background expression intensity, and is shown as a ratio of average PLLP pixel intensity to 
average background pixel intensity.  *p < 0.05. Bars represent mean ± SEM. 
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associate with both Cxcr4b and Cxcl12a, and to be critical to certain downstream signaling 
pathways activated by Cxcl12a [86-88]. To determine if chemokine signaling might be 
altered in sdc4 mutants, we looked at expression of cxcr4b and cxcr7b, the two chemokine 
ligand receptors expressed within the PLLP. Both genes show marked upregulation in sdc4 
mutant PLLP (Figure 2.2.9A, B, D, E), with significantly greater intensity of expression, 
as compared to wild-type (Figure 2.2.9 C and F). The upregulation of cxcr4b in mutants 
may well be due to the ectopic activation of Wnt signaling, as Wnt signaling has been 
proposed to facilitate expression of this chemokine receptor [8]. It is uncertain what 
Figure 2.2.9: Sdc4 mutants have increased expression of chemokine receptors. (A,B) Representative 
images show increased expression of cxcr4b in sdc4 mutants. (C) Analysis of in situ hybridization staining 
intensity shows significantly increased expression in mutants (WT n=20, Δsdc4 n=15). (D,E) 
Representative images show increased expression of cxcr7b in sdc4 mutants. (F) Analysis of in situ 
hybridization staining intensity shows significantly increased expression in mutants (WT n=20, Δsdc4 
n=12). Expression intensity is normalized to background expression intensity, and is shown as a ratio of 
average PLLP pixel intensity to average background pixel intensity.  *p < 0.01. Bars represent mean ± 
SEM. 
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signaling network is responsible for the upregulation of its expression in sdc4 mutants. 
Both Cxcr4b and Cxcr7b are necessary to maintain consistent migration of the PLLP from 
anterior to posterior, and the loss of either receptor results in a failure of directed migration 
[20, 21]. Perhaps the increase in cxcr7b is the result of a compensatory mechanism that is 
responding to the Wnt-induced increase in cxcr4b, allowing a similar upregulation in the 
expression of both receptors. Although the expression of the two receptors is changed, the 
balance between cxcr4b and cxcr7b is maintained, preserving the local cxcl12a gradient 
they create along the length of the PLLP. 
 
Inhibiting Fgf signaling within the PLLP in sdc4 mutants suggests a role for Sdc4 in 
migration 
Although sdc4 mutants show no obvious neuromast or PLLP migration phenotype, 
CRISPR mutants have been shown to compensate for mutations deleterious to their 
signaling network [115]. We hypothesized that despite such compensation, the genetic 
regulatory network might not be as robust and thus be much more susceptible to 
manipulations that perturb the system. In order to reveal any vulnerabilities specific to the 
sdc4 mutants, we wanted to simultaneously compromise the function of the signaling 
systems that normally work in concert with Sdc4. Since our morpholino studies and 
previous work by other researchers indicate a role for Sdc4 in Fgf signaling, we 
hypothesized that in the context of sdc4 loss, mild inhibition of the Fgf signaling network 
within the PLLP may cause stronger defects in sdc4 mutants than in wild-type siblings. 
 Morpholino-induced knockdown of fgf10, one of the two Fgfs expressed in the 
PLLP, delays the establishment of FgfR signaling within the PLLP and subsequent 
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protoneuromast formation and deposition [12]. This phenotype is usually seen after 
injecting a 4ng dose of fgf10MO into wild-type embryos. In order to draw out the 
vulnerabilities of the sdc4 mutants without causing too strong a defect in wild-type 
embryos, we used a low dose of the fgf10 morpholino (1ng) that causes little or no 
phenotype in wild-type embryos. Interestingly, in sdc4 mutants injected with a low dose of 
fgf10 morpholino, the PLLP has completed a significantly smaller fraction of its migration 
to the tip of the tail at 48hpf, a time by which most wild-type PLLP have almost completed 
this journey (Figure 2.2.10A, B, and E). By 72hpf, PLLP migration to the tail tip is 
completed in all embryos; however, sdc4 mutants injected with fgf10 morpholino have 
deposited an additional neuromast compared to wild-type siblings also injected with the 
fgf10 morpholino (Figure 2.2.10C, D, and F). The difference in migration distance at 48hpf 
suggested that fgf10 knockdown in sdc4 mutants causes slow PLLP migration, allowing 
time for the deposition of an extra neuromast prior to termination, as is observed at 72hpf. 
Indeed, measurement of migration speed in time-lapse movies demonstrates that sdc4 
mutant PLLP migrate significantly slower than their wild-type siblings, when both are 
injected with the fgf10 morpholino (Figure 2.2.10G and Supplementary Movie 2).  
Using an alternate strategy that also targets Fgf signaling, we looked for differences 
in PLLP behavior in sdc4 mutants following exposure to NaClO3. NaClO3 inhibits 
formation of the sulfation donor 3’-phosphoadenosine 5’-phosphosulfate (PAPS), thereby 
inhibiting three major types of sulfation (N-sulfation, 2-O-sulfation, and 6-O-sulfation) that 
are usually performed on the HS chain during biosynthesis and altering the ability of HS 
to bind to target signaling molecules [108]. When wild-type embryos are treated with 
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200mM of NaClO3, the PLLP stalls and Fgf signaling within the PLLP is compromised 
[39]. When sdc4 mutants are treated with a low dose of NaClO3 (100mM), the PLLP stalls 
and terminates earlier in sdc4 mutants, as compared to wild-type siblings treated with the 
same dose (Figure 2.2.10H- J).  
 
Figure 2.2.10: Inhibition of Fgf signaling in sdc4 mutants causes migration defects. (A,B,E) The PLLP 
in WT embryos injected with a low dose of fgf10MO (1ng) have migrated significantly further than the PLLP 
in sdc4 mutant siblings also injected with fgf10MO (migrating PLLP marked by yellow arrow; WT n=14, 
Δsdc4 n=14). (C,D,F) At 72hpf, PLLP migration finished and sdc4 mutants have one extra deposited 
neuromast (marked by a red arrow), as comopared to WT siblings (WT n=21, Δsdc4 n=25). (G) The 
difference in migration distance and extra neuromast are due to significantly slower migration speed, as 
confirmed by measurement of the migration speed in time-lapse movies (WT n=6, Δsdc4 n=5). (H,I,J) 
Treatment with a low dose of NaClO3 (100mM) specifically causes stalling and termination earlier in sdc4 
mutants, as compared to WT siblings (arrows mark distance left to migrate; WT n=8, Δsdc4 n=12). *p < 
0.05. Bars represent mean ± SEM. 
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Sdc3 works with Sdc4 to support neuromast formation and PLLP migration 
 The migration defects seen in sdc4 morphants and in sdc4 mutants with disturbed 
PLLP signaling support the hypothesis that Sdc4 plays some role in regulating migration 
of the PLLP. Since sdc4 mutants show no migration defects without signaling 
manipulation, it seems that Fgf signaling and other PLLP HSPGs, either together or 
independently, work to compensate for the loss of Sdc4. A search of the literature 
suggested that Syndecan3 (Sdc3), another syndecan homolog, makes a particularly 
attractive candidate. Sdc3 is expressed throughout the PLLP [39] and the protein has a 
relatively similar structure to that of Sdc4. Although Sdc3 cannot always compensate for 
the loss of Sdc4 [104], there is some evidence that Sdc3, like Sdc4, also has a role in Fgf 
signaling [116, 117]. 
Sdc3 morphants do exhibit some of the same defects as sdc4 morphants. They have 
fewer neuromasts and also have increased spacing between pairs of neuromasts, but have 
no apparent defect in migration (Figure 2.2.11A- D). To test the idea that Sdc3 compensates 
for the loss of Sdc4 in sdc4 mutants, we injected a low dose of a sdc3 morpholino into sdc4 
mutants. Mutants with sdc3 knocked down do, in fact, show similar defects as Fgf-
suppressed sdc4 mutants. At 48hpf, they are significantly delayed along the path of 
migration due to a slower rate of migration speed (Figure 2.2.11 E-H and Supplementary 
Movie 3). These findings therefore indicate that Sdc3 does compensate for the absence of 
Sdc4 in mutants and support the hypothesis that Sdc3, like Sdc4, can facilitate Fgf signaling 
when necessary.  
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2.3 Discussion  
 The interplay of Wnt and Fgf signaling is critical to morphogenesis of the zebrafish 
lateral line, as these signaling pathways help direct the central processes of collective cell 
migration and protoneuromast formation. However, the mechanisms that regulate these 
signaling pathways and control PLL morphogenesis are not fully understood. HSPGs 
regulate cell signaling, including Wnt and Fgf, in a wide variety of contexts and are 
expressed throughout animal tissues. One particular HSPG core protein, Sdc4, is very 
specifically expressed within the PLLP. We began this study with the intent of 
understanding how Sdc4 might regulate PLLP signaling and morphogenesis of the PLL. 
 We have shown that Sdc4 is an integral member of the signaling pathways that 
pattern the PLLP. Our results suggest that Sdc4 promotes Fgf signaling, as the loss of Sdc4 
Figure 2.2.11: Knockdown of sdc3 causes migration defects in sdc4 mutants. (A,B,C,D) Sdc3 
morphants have fewer neuromasts that are more spaced out, compared to WT (yellow arrow marks the 
still-migrating PLLP; WT n=20, sdc3MO n=20). (E,F,G) In sdc4 mutants injected with a low dose of the 
sdc3 morpholino, the PLLP has not migrated as far as WT siblings also injected with the sdc3 morpholino 
(arrow marks distance left to migrate; WT n=16, Δsdc4 n=19). (H) Sdc4 mutants injected with the sdc3 
morpholino have a slow rate of PLLP migration (WT n=8, Δsdc4 n=16.) *p < 0.05. Bars represent mean 
± SEM. 
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in morphants and mutants weakens Fgf signaling output, and leaves embryos vulnerable to 
changes in protoneuromast formation and PLLP migration speed. Meanwhile, Fgf 
signaling negatively regulates sdc4 expression, thereby establishing a negative feedback 
loop to moderate its own function. Thus, we identify Sdc4 as a player in the known 
functions of Fgf signaling in the PLLP. 
 We found that sdc4 is expressed in the trailing domain, where we traditionally 
consider Fgf signaling to be the dominant signaling network. A closer inspection of sdc4 
expression revealed that the strongest sdc4 expression is in the next-to-be-deposited cells 
of the PLLP and in deposited neuromasts. In these regions, Fgf signaling activity actually 
tapers off, so although both Fgf activity and Sdc4 are present in trailing cells, they do not 
occupy identical regions within the trailing domain.  
 In order to determine what regulates expression of sdc4, we artificially manipulated 
signaling networks to see how this impacted sdc4. We find that Wnt signaling represses it, 
excluding Sdc4 from the leading zone. In trailing cells, Fgf signaling also represses sdc4 
expression, indicating a negative feedback loop where Sdc4 promotes Fgf activity that then 
suppresses sdc4. Though our results show that sdc4 expression is suppressed by Fgf 
signaling, this finding contradicts an earlier Sdc4 regulation study in the PLLP. In a paper 
published last year, Venero Galanternik, et al. (2015) showed that SU5402 treatment 
suppresses sdc4 expression [39]. The reasons for this discrepancy remain unclear at this 
time. 
 Interestingly, our sdc4 regulation experiments yielded some contradictory results 
that led us to formulate additional hypotheses for how Sdc4 is regulated. We ectopically 
activated Wnt signaling using BIO treatment, which moderately repressed sdc4 expression. 
	 46	
We also artificially suppressed Fgf signaling through SU5402 treatment, which 
dramatically expanded sdc4 expression. However, SU5402 has a dual impact on PLLP 
signaling: while it inhibits Fgf signaling, it allows for the expansion of Wnt signaling, 
which is normally repressed in trailing cells by Fgf activity. Thus, despite the fact that BIO 
and SU5402 both ectopically activate Wnt signaling throughout the primordium, the 
former suppresses sdc4 expression, while the latter expands it. One important difference 
between these two manipulations, however, is that while exposure to BIO increases Wnt 
signaling, it also increases Fgf expression and this, in turn, is associated with an increase 
in Fgf signaling. On the other hand, the increase in Wnt signaling associated with exposure 
to SU5402 is associated with reduced Fgf signaling. Ultimately, whether sdc4 is increased 
may depend less on whether Wnt activity is increased, and more on whether Fgf signaling 
is decreased. While reduced Fgf signaling correlates with increased sdc4 expression, its 
expression was also increased following exposure to K02288, a chemical expected to 
inhibit BMP signaling. This raised the possibility that sdc4 expression was also negatively 
regulated by BMP signaling. While this remains a possibility, there was something in 
common with all the chemical treatments that were associated with increased sdc4 
expression: all these manipulations were associated with slower or stalled migration of the 
PLLP. As sdc4 is normally expressed in trailing cells that are beginning to slow down or 
have been deposited, we hypothesized that progressive loss of migratory behavior may 
itself be associated with increased sdc4 expression. To begin exploring this idea, we looked 
at sdc4 expression in cxcl12a morphants, in which the PLLP does not migrate along the 
horizontal myoseptum and is stalled at the migration start point. Sdc4 expression is 
increased in these morphants, in support of our hypothesis (Figure 2.2.3A-C). A potential 
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role for migratory behavior in suppressing sdc4 expression, though interesting, remains 
speculative at this time, and many more experiments would need to be done to test this 
hypothesis. For example, we need to determine if other manipulations that stall migration, 
without obvious effects on the Wnt, Fgf, BMP, and chemokine signaling pathways, also 
result in increased sdc4 expression. Another prediction of this hypothesis is that sdc4 
expression may be broader in the PLLP early in its development, before its migratory 
behavior is initiated. Identification of the signaling network(s) that activate Sdc4 activity 
would help to promote our understanding of the role Sdc4 plays in PLL development, and 
provide clues as to its function in other contexts. 
 Our investigation into the role of Sdc4 in PLL development centered around the 
phenotypes resulting from the loss of Sdc4 activity. Preliminary experiments used a 
morpholino to knock down sdc4. These experiments suggested that Sdc4 regulates Fgf 
signaling activity and is specifically involved in collective cell migration and 
protoneuromast formation, both of which are functions of Fgf signaling. Still, morpholinos 
are known to cause a number of off-target effects, which can include expanded Wnt 
signaling and apoptosis, both of which we observed in sdc4 morphants. We therefore 
generated sdc4 mutants using the CRISPR/Cas9 system, intending to confirm our 
conclusion that Sdc4 regulates Fgf signaling. Sdc4 mutants, generated by CRISPR, display 
a decrease in Fgf signaling and an expansion of Wnt signaling, indicating that the signaling 
changes we observed in morphants were due, at least in part, to the loss of Sdc4 and not 
the off-target effects of morpholinos. However, the PLLP migrates at a normal speed in 
mutants and lays down a normal pattern of neuromasts. There are several reasons that could 
explain why the phenotype in sdc4 mutants is weaker than the one observed in morphants. 
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First, studies show that compensatory networks can make up for the loss of certain genes 
in CRISPR/Cas9-generated mutants, whereas the same compensatory networks are not 
activated when morpholinos target the same genes [115]. Indeed, the increased expression 
of lef1, cxcr4b, and cxcr7b in sdc4 mutants may represent changes in the network that 
reflect such compensatory behavior. We tested the hypothesis that some factor 
compensates for the loss of Sdc4 and found this to be true. Sdc4 mutants are more 
vulnerable to manipulation of Fgf signaling than are wild-type embryos, and exhibit 
migration defects as a result of partial Fgf inhibition. Another potential reason for the weak 
phenotype in sdc4 mutants is that other HSPG(s) could be the compensating factor(s) 
supporting Fgf signaling. After all, individual syndecan mouse mutants are also 
macroscopically indistinguishable from wild-type mice [118, 119]. In addition to Sdc4, 
several other HSPG core proteins are expressed in the PLLP, including another syndecan, 
Sdc3 [39]. Sdc3 is broadly expressed throughout the PLLP, thus overlapping sdc4 
expression, and all syndecans possess a generally similar structure. Although there is not 
an extensive literature on Sdc3, there is some evidence that Sdc3 can regulate Fgf signaling 
[117]. These characteristics make Sdc3 an ideal candidate for an HSPG that can 
compensate for the loss of Sdc4. As sdc3 knockdown in sdc4 mutants causes slow PLLP 
migration (a phenotype the sdc3 morpholino is not capable of causing alone), it seems 
likely that these two syndecans are both capable of supporting Fgf signaling.  
 To further qualify the role of Sdc4 signaling in PLL development, we wanted to 
overexpress sdc4. We did this through injection of sdc4 mRNA; unfortunately, the 
resulting changes in dorsoventral axis patterning made specific evaluation of the lateral 
line difficult. Still, the exaggerated expression of Fgf-responsive genes and ultimate 
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dorsalization of the embryo in response to sdc4 overexpression supports our model that 
Sdc4 supports Fgf signaling in the trailing cells of the PLLP. More PLLP-specific sdc4 
overexpression could be achieved by PLLP-specific promoter-driven sdc4 expression to 
circumvent the problems created by dorsoventral patterning. 
 Our conclusion that Sdc4 facilitates Fgf signaling and its downstream functional 
roles fits well with the previously known signaling functions of Sdc4. Many studies of 
Sdc4 have demonstrated that it can support Fgf signaling, both as a co-receptor to FgfR 
and as an independent receptor (reviewed in [120]). Sdc4 stabilizes the binding of Fgf 
ligand to FgfR, resulting in more sustained MAPK/ERK signaling [63-65], and allowing 
for activation of intracellular signaling with lower absolute concentration of the Fgf ligand 
[121]. Even in the absence of a functional FgfR, Fgf can still transiently activate ERK1/2 
signaling, using Sdc4 as its receptor and activator of intracellular signaling [106]. Given 
this context, and the knowledge that sdc4 expression is strongest in the most trailing cells 
of the PLLP that are furthest from the population of Fgf-producing cells in the leading 
domain, perhaps Sdc4 helps sustain neuromast maturation in this area where Fgf ligands, 
secreted in response to Wnt signaling in leading cells, are less available. 
 Fgf signaling has three defined functions within the migrating PLLP. First, Fgf 
organizes cells into protoneuromasts, through the epithelialization of cells and the 
organization of those cells into neuromasts [9, 10]. Second, within each protoneuromast, 
Fgf signaling initiates center-biased atoh1a expression which specifies that cell to become 
the sensory hair cell progenitor [9, 27]. Lastly, Fgf ligands act as migrational cues to trailing 
cells; while the leading cells guide directional PLLP migration via chemokine signaling, 
trailing cells are induced to migrate and follow the leading cells by Fgf signals [26]. Our 
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results demonstrate that Sdc4 regulates at least two of these Fgf-mediated processes; 
namely, protoneuromast formation and cell migration. The PLLP in sdc4 morphants 
contains fewer protoneuromasts, while both morphants and Fgf-inhibited mutants all 
display slower rates of PLLP migration. 
 Our conclusion that Sdc4 supports cell migration is consistent with previous 
findings that Sdc4 is involved in the regulation of directional migration of neural crest cells 
[109]. Although we conclude that Sdc4 supports PLLP migration via Fgf signaling, it is 
worth noting that Sdc4 also has a documented role in chemokine signaling, which is also 
critical to PLLP migration. Sdc4 is a binding partner for both Cxcl12a and Cxcr4, critical 
to some downstream signaling of Cxcr4 [87, 88]. While it is theoretically possible the Sdc4 
and Cxcr4 interact in the PLLP to mediate migration, this seems unlikely given their 
respective expression domains. Cxcr4b is expressed in the leading two thirds of the PLLP 
[23], while the strongest sdc4 expression is in the most trailing cells. Although their 
domains of expression may overlap, the somewhat disparate expression patterns of cxcr4b 
and sdc4 suggest that Sdc4 is not a key co-receptor for Cxcl12a in this system. Given the 
expression of sdc3 throughout the PLLP, it is possible that Sdc3 interacts with the 
chemokine signaling system. However, our results suggest that Sdc3 only plays a role in 
migration in the absence of Sdc4. 
 We conclude that Sdc4 promotes Fgf signaling in the formation of 
protoneuromasts, but we have not explored any possible functions of Sdc4 in mature 
neuromasts. We know that sdc4 is strongly expressed in deposited neuromasts, even many 
hours after deposition. The neuromasts deposited in sdc4 morphants appear to be stable, 
when observed in time-lapse movies (Supplementary Movie 1), but perhaps the neuromasts 
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in morphants or mutants experience defects in the longer term that we have not 
comprehensively analyzed. One avenue worth exploring is the differentiation of the central 
cell into sensory hair cells. The central cell becomes a new source of Fgf10a, activated by 
Atoh1a, which then binds to FgfR1 on neighboring peripheral cells and helps to ensure 
their fate as support cells [27]. If Sdc4 helps mediate this interaction in maturing 
neuromasts, then weak Fgf signaling in peripheral cells might push would-be support cells 
towards a sensory hair cell fate. It would be of interest to examine the neuromasts of 
morphants and/or mutants to see if they have a normal number of hair cells in future studies.  
Another unexplored line of inquiry is the regeneration of hair cells. Lateral line 
neuromasts are fully capable of regenerating hair cells even if all existing hair cells die 
(reviewed in [122]). While Notch and Wnt signaling typically work together to organize 
the regeneration of hair cells in the PLL, targets of Fgf signaling are downregulated in the 
neuromast immediately following hair cell death [123]. We also know that Fgf signaling 
is critical to hair cell specification during development [27] and there is some evidence that 
Fgfs to have a functional role in hair cell regeneration in the avian ear [124]. A similar 
hypothesis has been proposed for the lateral line, positing that Fgf is involved in the 
regeneration of lateral line hair cells [122, 125], but whether Fgf signaling actually does 
assist Notch and Wnt in this process is still unknown. If Fgf is indeed involved in hair cell 
regeneration, then this would also implicate Sdc4. One preliminary experiment could be to 
subject sdc4 mutants to stimuli that would promote hair cell apoptosis and assess if they 
regenerate the proper number of hair cells in the same time frame as wild-type embryos.  
Our study illustrates how one HSPG core protein, Sdc4, is regulated by signaling 
networks within the PLLP, and how it, in turn, influences lateral line development through 
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its own regulation of those signaling networks. Repressed by both Wnt and Fgf signaling 
in the leading and middle cells of the primordium, Sdc4 is present in the most trailing cells, 
where it promotes Fgf signaling and the downstream processes of cell migration and 
protoneuromast maturation. These findings contribute to our understanding of how the PLL 
develops, as well as our broader knowledge of how HSPGs regulate intercellular signaling. 
 
2.4 Appendix  
Three movies of PLLP migration made by time-lapse imaging are referenced in this 
chapter. The full-length movies, the titles of which are listed below, are available in the 
supplemental files for this dissertation.  
1) Supplemental Movie 1 – WT and Sdc4MO PLLP migration.avi 
2) Supplemental Movie 2 – WT and Sdc4 mutant with 1ng Fgf10MO.avi 
3) Supplemental Movie 3 – WT and Sdc4 mutant with 2ng Sdc3MO.avi  
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Chapter 3: 3-O-sulfated heparan sulfate supports Fgf signaling in the 
zebrafish lateral line 
3.1 Introduction 
The structure of HS chains is highly variable because they are decorated with a 
wide assortment of modifications. The degree to which a chain is modified, and the pattern 
of those modifications, is thought to determine the specificity of any given HSPG, allowing 
them to bind specific targets. Thus, as a group, HSPGs are capable of binding to many 
different types of signaling ligands and cell surface proteins, while individual HSPGs can 
have very specific targets and functions. While the previous chapter examined the role of 
one type of HSPG core protein and its impact on PLL development, now we focus in on 3-
O-sulfation, a unique type of modification made to HSPGs. Recent research into signaling 
regulation within the PLLP demonstrates that, taken as a whole, the sulfation modifications 
made to HSPGs are critical to Fgf signaling and protoneuromast formation [39], but we 
wanted to investigate the specific role(s) of 3-O-sulfation. This modification has been 
shown to promote Fgf signaling during development [90] and two of the enzymes that 
generate this modification are specifically expressed within the PLLP [62].  
After the core HSPG protein is synthesized, it is transported to the Golgi apparatus, 
where a series of enzymes build the HS chains onto the core protein and modify them in a 
step-wise manner. Briefly, a tetrasaccharide linker is attached to specific serine residues in 
the core protein, glycosyltransferases attach alternating glucosamine and glucuronic acid 
subunits, and then certain subunits are epimerized and/or sulfated. The last step in this 
process is 3-O-sulfation of some glucosamine subunits by heparan sulfate 3-O-
sulfotransferases (Hs3sts).  
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Rarity and types of 3-O-sulfation 
 Of all the modifications made to the HSGAG chain, 3-O-sulfation is the rarest, 
although its prevalence is understudied and varies based on the source of HS. In bovine 
aortic endothelial cells, 1% of disaccharides are 3-O-sulfated [126]. The level of 3-O-
sulfated disaccharides rises to 5% in mouse Reichert’s basement membrane cells, but the 
same study showed that basement membrane cells isolated from Engelbreth-Holm-Swarm 
tumors had 0% 3-O-sulfation [127]. HS in human follicular fluid contain 6% 3-O-sulfated 
glucosamine residues [128]. In general, 3-O-sulfation is believed to account for less than 
1% of sulfation events on HS [60, 61]. And yet, vertebrates have more homologous genes 
for Hs3st than for any other enzyme in the HSGAG biosynthesis pathway. The zebrafish 
genome contains eight Hs3st genes and each one has a unique expression pattern and set 
of binding partners, suggesting regulatory and functional divergence [62].  
Although all eight Hs3st isoforms add a 3-O-sulfate to glucosamine residues, these 
modifications come in two different flavors. The first subgroup of isoforms (Hs3st1-like), 
which includes Hs3st1 and Hs3st1l1, generates ‘AT-type’ 3-O-sulfation, so-called due to 
the ability of antithrombin to bind to this type of modification [129]. These enzymes are 
intraluminal and lack the typical transmembrane domain of other HSGAG synthesis 
enzymes. AT-type sulfation generally occurs on HexA-GlcNS or HexA-GlcNS6S residues 
that lack 2-O-sulfation [130, 131]. The second subgroup (Hs3st3-like isoforms), which 
includes Hs3st2, Hs3st3b1a, Hs3st3b1b, Hs3st3l, and Hs3st4, produce ‘gD-type’ 3-O-
sulfation, to which the glycoprotein gD of type I herpes simplex virus (HSV-1) 
preferentially binds [132]. Unlike the AT-type subgroup, gD-type Hs3sts are type II 
transmembrane domains with a short cytoplasmic domain at the N-terminal, a hydrophobic 
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α helix that crosses the Golgi membrane, a so-called SPLAG domain (enriched in Ser, Pro, 
Leu, Ala, and Gly residues) that may serve as a flexible connecting arm, and a large C-
terminal catalytic domain [133]. This subgroup of Hs3sts is known to target GlcA2S-
GlcNS, IdoA2S-GlcNS, and IdoA2S-GlcNH2 residues [134]. Unique among Hs3sts, 
Hs3st1l2 is capable of generating both AT- and gD-type binding sites [135]. Two of the 
Hs3st3-like isoforms, hs3st3b1a and hs3st3b1b, are specifically expressed in the PLLP 
[62]. The specific roles of each type of 3-O-sulfation are understudied, but Hs3st3-like 
sulfation has been shown to promote Fgf10 signaling in epithelial progenitor cells of the 
mouse fetal salivary gland [90].  
	
Specific roles for 3-O-sulfation 
 The modifications made to the GAG chain are frequently essential to the functional 
roles of HSPGs. Most ligands bind to highly sulfated regions, or at the borders between 
modified and unmodified stretches of the GAG chain [136]. Some ligands recognize certain 
structural motifs as their specific binding sites and therefore require a specific pattern of 
sulfation to bind HS. In 3T3 fibroblasts, three different Fgf ligands were shown to have 
distinct sulfation requirements in order to bind HS and promote downstream activity [137]. 
Fgf2 required 2-O-sulfation, Fgf1 required both 2- and 6-O-sulfation, and Fgf4 required 
unsulfated GAG sequences. Another study showed that N-sulfation and, to a lesser extent, 
O-sulfation, were critical for formation of the ternary complex between HS, Fgf1, and 
FgfR1 [138]. 
 Although many proteins have been identified as HSPG binding partners, few 
studies have specifically examined the effect of 3-O-sulfation on binding. But despite their 
relative rarity, 3-O-sulfation sites can also be a critical component of a ligand binding site 
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on HS. As previously mentioned, antithrombin and gD preferentially bind to certain 3-O-
sulfated sites. Antithrombin is an anticoagulant whose catalytic activity is greatly enhanced 
when bound to HS. It was the first binding partner to be identified for 3-O-HS, when 3-O-
sulfate was identified as a critical component of the antithrombin-binding sequence on HS 
[139, 140]. During HSV-1 infection, gD-type 3-O-sulfation is critical to viral entry into 
target cells. It has been shown that gD selectively binds to Hs3st3b1a-modified HS, thereby 
facilitating virion fusion with the cell and promoting HSV-1 infection [141]. 
 In addition to antithrombin and gD, several other ligands also show specificity for 
3-O-sulfated HS and, in some cases, these ligands have been shown to have a preference 
for AT-type or gD-type sites. In epithelial KIT+ progenitor cells isolated from mouse fetal 
salivary glands, FgfR2b preferentially interacts with gD-type 3-O-sulfation, and Hs3st3-
modified HS enhances formation of the ternary complex between HS, Fgf10, and FgfR2b 
[90]. Clearance of circulating HS is mediated by liver sinusoidal endothelial cells by 
stabilin. In cell culture, cells expressing stabilin take up AT-type Hs3st1-modified HS more 
efficiently than non-3-O-sulfated HS, and this uptake is inhibited in the presence of 
antithrombin [142]. Cylophilin B binds to cell-surface HS on peripheral blood T 
lymphocytes and triggers migration and adhesion of these cells. This binding interaction is 
lost, as is downstream activation of ERK1/2, when gD-type 3-O-sulfation is downregulated 
by siRNA knockdown of human hs3st3b [143]. Although a specific binding partner hasn’t 
been identified, two Hs3sts regulate left-right patterning by Kupffer’s vesicle in zebrafish. 
AT-type Hs3st1l2 regulates cilia length via Fgf signaling, while gD-type Hs3st3l functions 
in cilia motility by activating Kinesin 3b expression and dynein assembly. Morpholino 
knockdown of either one disrupts proper patterning [144]. Within the PLLP, two gD-type 
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3-O-sulfotransferases, hs3st3b1a and hs3st3b1b, are very specifically expressed [62]. 
Given that HSPGs frequently play a role in signaling pathways that are critical to PLLP 
patterning and migration, and that gD-type 3-O-sulfation can be critical for ligand binding, 
Hs3st3b1a and Hs3st3b1b are a particular focus of this chapter.  
 In this study, we focus on the role of Hs3st3b1a and Hs3st3b1b in the PLLP. We 
find that hs3st3b1a and hs3st3b1b expression is activated in the leading zone by Wnt 
signaling. However, despite their presence in leading cells, these two enzymes facilitate 
Fgf signaling, which is active in the trailing domain. Loss of Hs3st3s in morphants results 
in decreased pea3 expression, fewer forming protoneuromasts, and fewer deposited 
neuromasts. Double hs3st3b1a/hs3st3b1b mutants generated using the CRISPR/Cas9 
system show similar defects, with fewer deposited neuromasts. We posit that Hs3st3s, 
present in the same cells that produce Fgf3 and Fgf10, regulate the delivery of Fgf ligands 
to trailing cells, where they activate their receptor. 
 
3.2 Results  
Wnt signaling activates expression of two Hs3st3 enzymes in the leading domain. 
 Previous research showed expression of both hs3st3b1a and hs3st3b1b in the PLLP 
[62]. To more specifically define the expression domains of these two genes, and how they 
change over time, we performed in situ hybridization over an 18-hour time course during 
the period of PLLP migration. Expression of both hs3st3b1a and hs3st3b1b is polarized 
from the start, restricted to the leading domain at 22hpf, just before PLLP migration begins 
(Figure 3.2.1H and O). At this stage of PLLP development, Wnt activity is still quite broad, 
as indicated by the expression of lef1, a marker of Wnt activity (Figure 3.2.1A). Although 
	 58	
Wnt activity does become polarized and lef1 expression becomes restricted to the leading 
domain, this process has not completed by 22hpf. Thus, the polarized expression of these 
two 3-O-sulfotransferases precedes the visible polarization of lef1 expression. As time and 
PLLP migration progress, the expression domains of lef1, hs3st3b1a, and hs3st3b1b all 
recede, becoming more and more restricted to the leading cells (Figure 3.2.1A-U). Lef1 
expression recedes most quickly, while the two sulfotransferases persist until late in 
migration, and hs3st3b1b persists the longest (Figure 3.2.1.V). 
Due to the fact that hs3st3b1a and hs3st3b1b are expressed in the leading domain, 
we hypothesized that they may be regulated by Wnt signaling. To elucidate which signaling 
networks regulates expression of these two enzymes, we treated embryos with a panel of 
Figure 3.2.1: Hs3st3b1a and hs3st3b1b are expressed in the leading domain. (A-G) Lef1 expression, 
while initially broad, recedes over time and becomes progressively more restricted to leading cells (22hpf 
n=12, 24hpf n=12, 26hpf n=12, 28hpf n=10, 32hpf n=10, 36hpf n=10, 40hpf n=9). (H-N) Polarized from 
the start of expression, hs3st3b1a expression also recedes during the course of migration (22hpf n=20, 24hpf 
n=15, 26hpf n=20, 28hpf n=11, 32hpf n=16, 36hpf n=19, 40hpf n=17). (O-U) Expression of hs3st3b1b is 
polarized and becomes more restricted to leading cells over time, but more slowly than lef1 or hs3st3b1a 
(22hpf n=19, 24hpf n=17, 26hpf n=19, 28hpf n=20, 32hpf n=19, 36hpf n=18, 40hpf n=20). (V) 
Quantification of expression domain size, as a fraction of primordium length, for lef1, hs3st3b1a, and 
hs3st3b1b throughout an 18-hour time course. *The length of the expression domain is significantly 
different than the length of the lef1expression domain, when p < 0.05. Plot points represent mean ± SEM. 
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chemical inhibitors and performed in situ hybridization for both hs3st3s. These 
experiments were performed simultaneously with in situ hybridization for lef1 and pea3, 
the expression of which demonstrates the efficacy of these inhibitors (Figure 3.2.2K-Q). 
The chemical inhibitor BIO prevents destruction of β-catenin through inhibition of GSK-
3, allowing the buildup of β-catenin and resultant ectopic activation of Wnt signaling, while 
a different inhibitor, IWR, stabilizes this destruction complex through inhibition of Axin, 
effectively inhibiting Wnt signaling. Treatment with BIO increases the intensity of both 
hs3st3s, whereas treatment with IWR, a Wnt inhibitor, suppresses expression of both 
hs3st3s (Figure 3.2.2A-C, F-H). SU5402 is an Fgf inhibitor that also causes a subsequent 
increase in Wnt signaling. Fgf normally suppresses Wnt signaling, and so the absence of 
Fgf activity in SU5402-treated embryos allows for the expansion of Wnt signaling. 
Treatment with SU5402 increases expression of hs3st3b1a while actually decreasing the 
expression level of hs3st3b1b, suggesting differential roles for Fgf signaling in the 
regulation of these two genes (Figure 3.2.2A, D, F, and I). Because ectopic activation of 
Wnt induced by BIO also causes the expansion of Wnt-activated expression of fgf3 and 
fgf10, simultaneous treatment with BIO and SU5402 more thoroughly suppresses Fgf 
activity and ectopically activates Wnt more than either treatment alone. This double 
inhibitor treatment causes an increase in the expression of both hs3st3b1a and hs3st3b1b 
(Figure3.2.2A, E, F, and J). These results indicate that Wnt signaling positively regulates 
expression of hs3st3b1a and hs3st3b1b. However, the role of Fgf signaling is slightly more 
complex. Expression of hs3st3b1b under BIO treatment is expanded, and although it does 
expand under BIO+SU5402 treatment, the expansion is not quite so dramatic. Because Wnt 
signaling initiates transcription of fgf3 and fgf10, in addition to upregulating Wnt activity, 
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Fgf activity also increases. Thus, the difference in hs3st3b1b expression under these two 
treatment conditions, plus the decrease in expression with SU5402 alone, suggests that Fgf 
and Wnt signaling are co-activators of hs3st3b1b. Meanwhile, similar expansions of 
hs3st3b1a occur under BIO, SU5402, and BIO+SU5402 treatments, indicating that 
hs3st3b1a only requires Wnt signaling for activation.  
Although Wnt signaling activates expression of both of these 3-O-sulfotransferases, 
their expression does not precisely mirror that of lef1, a classic marker of Wnt activity. 
Unlike Lef1, the expression of Hs3st3s is polarized from the start, and the rate at which 
they recede is different. This suggests that other factors regulate expression of hs3st3b1a 
and hs3st3b1b. We have already established that Fgf signaling is likely a co-activator of 
hs3st3b1b, but perhaps there is some other co-activator that regulates expression of one or 
both of these genes. It is also possible that hs3st3 genes and lef1 have differential sensitivity 
to Wnt activation and that hs3st3s require a very high level of Wnt activity which is only 
present in the leading domain. Alternatively, there may be a repressor that negatively 
regulates expression of hs3st3s and prevents their expression from the trailing domain. 
Figure 3.2.2: Wnt activates expression of hs3st3b1a and hs3st3b1b. (A-E) Hs3st3b1a expression in 
DMSO, IWR, BIO, SU5402, and combined BIO+SU5402 treatment conditions (DMSO n=18, IWR n=17, 
BIO n=21, SU5402 n=23, BIO+SU5402 n=20). (F-J) Hs3st3b1b expression in DMSO, IWR, BIO, SU5402, 
and combined BIO+SU5402 treatment conditions (DMSO n=19, IWR n=21, BIO n=16, SU5402 n=20, 
BIO+SU5402 n=18). (K-N) Lef1 expression in DMSO, IWR, BIO, and combined BIO+SU5402 treatment 
conditions (DMSO n=14, IWR n=18, BIO n=17, BIO+SU5402 n=17). (O-Q) Pea3 expression in DMSO, 
SU5402, and combined BIO+SU5402 treatment conditions (DMSO n=17, SU5402 n=11, BIO+SU5402 
n=10). 
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Even when embryos are treated with BIO or BIO+SU5402, expression of hs3st3b1a and 
hs3st3b1b is excluded from the most trailing cells of the primordium, despite the fact that 
lef1 expression and Wnt activity has expanded throughout the PLLP and even into the trail 
of depositing cells behind the PLLP. Fgf signaling is prominent in the trailing domain and 
would seem to be an obvious candidate for the repressor role, but given our results thus far, 
this signaling network activates hs3st3b1b and has no obvious role in the regulation of 
hs3st3b1a. 
 
Knockdown of hs3st3s results in fewer neuromasts. 
In order to determine the role of Hs3st3 activity in the PLLP, we used morpholinos 
to knock down hs3st3 activity. We knocked down hs3st3b1a and hs3st3b1b individually 
and simultaneously, and measured the number of neuromasts, as well as the spacing 
between pairs of neuromasts (Figure 3.2.3A-F). Morphants typically have two fewer 
neuromasts than their wild-type siblings; hs3st3b1a morphants and hs3st3b1a/hs3st3b1b 
double morphants have two fewer neuromasts, while hs3st3b1b morphants have one fewer 
neuromast than wild-type embryos. Hs3st3b1a morphants and hs3st3b1a/hs3st3b1b double 
morphants also have increased spacing between most pairs of neuromasts, while spacing 
changes in hs3st3b1b morphants is subtler. Two morpholinos, both splice-blocking and 
translation-blocking, were used against the hs3st3 homologs and all resulted in similar 
phenotypes. Given that double morphants strongly resemble single hs3st3b1a morphants, 
and hs3st3b1b had a less severe phenotype, in future analyses, we focused on hs3st3b1a 
single morphants. At high dosages, morpholinos can have toxic effects, so the use of a 
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single hs3st3 morpholino was intended to decrease these toxic and off-target effects.  A 
more detailed analysis of hs3st3b1a morphants can be found in Figure 3.2.4. Of particular 
interest is that hs3st3b1a morphants have no change in migration speed (Figure 3.2.4F and 
Supplementary Movie 4). More complete inhibition of HSPG sulfation, through treatment 
with NaClO3, results in slowing and eventual stalling of PLLP migration, as well as the 
formation of ectopic filopodia, demonstrating that sulfation is generally critical to HSPG 
function in the PLLP [39]. It seems that when just 3-O-sulfation is inhibited, through 
morpholino-mediated knockdown of the 3-O-sulfotransferases, PLLP migration is not 
Figure 3.2.3: Hs3st3 morphants have fewer deposited neuromasts. (A) WT embryos typically have six 
neuromasts, as well as a terminal cluster of neuromasts at the tip of the tail (n=20). (B) Hs3st3b1a morphants 
have four neuromasts deposited along the trunk (n=20). (C) Hs3st3b1b morphants have about five trunk 
neuromasts (n=20). (D) Double hs3st3b1a/hs3st3b1b morphants have four neuromasts (n=20). (E) All hs3st3 
morphants have fewer neuromasts than WT, but hs3st3b1a morphants and hs3st3b1a/hs3st3b1b double 
morphants have the fewest (**p < 0.0001, *p < 0.01). (F) Hs3st3b1a morphants and hs3st3b1a/hs3st3b1b 
double morphants have increased spacing between pairs of neuromasts, while hs3st3b1b morphants only 
have increased spacing between the last pair of neuromasts (*p < 0.05). Bars represent mean ± SEM. 
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impacted. The more limited phenotype we see in morphants suggests that this rare type of 
HSPG sulfation has a much more modest role in regulating PLLP signaling.  
Increased spacing between neuromasts and fewer deposited neuromasts in 
hs3st3b1a morphants suggested that protoneuromast formation may be compromised in 
morphants. To test this, we looked to see if morphants have fewer protoneuromasts by 
analyzing time-lapse movies. Time-lapse frames were analyzed for protoneuromast 
number at seven intervals between 27hpf and 33hpf. Wild-type primordia generally had 3-
4 protoneuromasts, while hs3st3b1a morphants tended to have 2-3 protoneuromasts 
Figure 3.2.4: Hs3st3b1a morphants have fewer neuromasts and their deposition appears to be delayed. 
(A-C) Morpholino-knockdown of hs3st3b1a causes a decrease in the number of deposited neuromasts (WT 
n=22, hs3st3b1aMO n=22). (D,E) Due to increased spacing between pairs of neuromasts, each neuromast is 
deposited significantly later along the path of migration, compared to WT. (F) Hs3st3b1a morphants have a 
normal speed of PLLP migration (WT n=3, hs3st3b1aMO=8). *p < 0.01. Bars represent mean ± SEM. 
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(Figure 3.2.5A-C). Although morphant primordia are shorter than wild-type primordia, 
they still had proportionally fewer protoneuromasts when PLLP length was taken into 
account. Additionally, the protoneuromasts within morphant primordia were located 
significantly further from the leading edge of the PLLP, relative to the length of the 
primordium (Figure 3.2.5D). Taken together, these results indicated the protoneuromast 
formation is delayed in hs3st3b1a morphants. Given that Fgf signaling is responsible for 
organizing trailing cells into protoneuromasts, the impaired formation of protoneuromasts 
suggested that Fgf signaling may be compromised in hs3st3b1a morphants. 
 
Figure 3.2.5: Hs3st3b1a morphants have fewer protoneuromasts. Frames from time-lapse movies were 
analyzed for neuromast number at seven hourly intervals (27hpf-33hpf). (A-C) WT primordia have 3-4 
protoneuromasts, while hs3st3b1aMO have only 2-3 protoneuromasts. Images show protoneuromasts in WT 
and hs3st3b1aMO, numbered and marked by arrows. Although hs3st3b1aMO primordia are shorter than WT 
primordia, they still had fewer neuromasts per unit of distance (WT n=42, hs3st3b1aMO n=35). (D)  Each 
protoneuromast (generically marked as NM1, NM2, and NM3 because measurements were made over the 
course of seven hours) is located further from the leading edge of the PLLP in morphants, relative to the 
length of the primordium. Arrows mark neuromast centers. *p < 0.01. Bars represent mean ± SEM. 
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Knockdown of hs3st3b1a decreases the size of the Fgf signaling domain. 
In order to determine the impact of hs3st3b1a knockdown on PLLP signaling, we 
performed in situ hybridization for lef1 and pea3 in hs2st3b1a morphants at 31hpf. Lef1 
expression appears to be relatively normal in morphants, indicating that 3-O-sulfation has 
little role in Wnt signaling (Figure 3.2.6A and B). Meanwhile, the pea3 expression domain 
is significantly shorter in length in morphants (Figure 3.2.6C-E), signifying that the Fgf 
signaling domain is decreased in size. The Fgf signaling domain is also located further 
from the leading edge of the PLLP (Figure 3.2.6F). This impairment in Fgf signaling is 
therefore the most likely cause for the delay in protoneuromast formation. 
The first Fgf signaling center (as indicated by pea3 expression) begins to establish 
at the most trailing end of the PLLP between 20 and 22hpf. Migration typically begins after 
2-3 protoneuromasts associated with Fgf signaling centers have begun to form and the Wnt 
system (defined by the domain of lef1 expression) becomes restricted to a smaller leading 
zone. As time continues and PLLP migration proceeds, subsequent Fgf signaling centers 
form, moving progressively closer to the leading domain. As Fgf signaling suppresses Wnt 
signaling, this process also restricts lef1 expression to the leading domain more and more. 
Although primordia migrate normally in hs3st3b1a morphants, the system fails to expand 
the Fgf signaling domain to the same extent as is seen in wild-type primordia. Thus, the 
distance of the pea3 expression domain and forming protoneuromasts from the leading 
edge in hs3st3b1a morphants suggests that the establishment of Fgf signaling is not as 
robust in these embryos.  
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 The PLLP is a dynamic system, and so a static picture of the system at any given 
time point can be misleading as to the reality of how it functions. To more thoroughly 
explore establishment of Fgf signaling in hs3st3b1a morphants, we performed in situ 
hybridization for pea3 at four time points over 12 hours during migration of the PLLP. In 
wild-type primordia, pea3 expression is fairly consistent, demonstrating that the Fgf 
system is fairly steady between 24 and 36hpf (Figure 3.2.7A-D). However, although pea3 
expression is clear in hs3st3b1a morphants at 24hpf, pea3 expression wanes over time and 
by the latter two time points, its domain is much shorter in length than in wild-type embryos 
(Figure 3.2.7E-I). Furthermore, despite having a normal-sized pea3 domain in the early 
Figure 3.2.6: Hs3st3b1a morphants have decreased Fgf signaling. (A,B) In situ hybridization for lef1 
marks the domain of Wnt activity. The lef1 expression domain is unchanged in hs3st3b1a morphants (WT 
n=15, hs3st3b1aMO n=12). (C,D) Pea3 expression marks the domain of active Fgf signaling (WT n=13, 
hs3st3b1aMO n=12). (E) The length of the pea3 domain, normalized to the length of the PLLP, is 
significantly shorter in hs3st3b1a morphants. (F) The pea3 domain is located significantly further from the 
leading edge in hs3st3b1a morphants. *p < 0.01. Bars represent mean ± SEM. 
	 67	
time points, at every time point, that domain is located further from the leading edge than 
in wild-type embryos (Figure 3.2.7J). Thus, although the pea3 expression domain in 
hs3st3b1a morphants seems to be normal in size early in PLLP migration, it is never as 
close to the leading edge as is normal and its size cannot be sustained for the duration of 
the PLLP’s journey. These results support our contention that the strength of the Fgf 
signaling system depends upon 3-O-sulfated HSPGs. 
 
Overexpression of hs3st3s causes dorsalization of zebrafish embryos.  
Having established that knockdown of hs3st3b1a impairs Fgf signaling and Fgf-
mediated protoneuromast formation, we wanted to know what impact overexpression of 
Figure 3.2.7: Hs3st3b1a morphants have decreased Fgf signaling. (A,B,C,D) In situ hybridization for 
pea3 in WT embryos at 24, 28, 32, and 36hpf (24hpf n=12, 28hpf n=11, 32hpf n=8, 36hpf n=13). (E,F,G,H) 
In situ hybridization for pea3 in hs3st3b1a morphants at 24, 28, 32, and 36hpf (24hpf n=10, 28hpf n=14, 
32hpf n=17, 36hpf n=10). (I) The length of the pea3 domain, normalized to the length of the PLLP, at 24, 
28, 32, and 36hpf. The domain is significantly smaller at 32 and 36hpf. (J) The distance of the pea3 domain 
from the leading edge, normalized to the length of the PLLP, at 24, 28, 32, and 36hpf. The domain is 
significantly further from the leading edge at all time points. *p < 0.05. Bars represent mean ± SEM. 
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hs3st3b1a and hs3st3b1b would have on development. Embryos were injected with either 
hs3st3b1a or hs3st3b1b mRNA individually, or co-injected with both mRNAs. Ectopic 
expression of hs3st3s causes dorsalization in all three cases (Figure 3.2.8A-D). The severity 
of dorsalization and overall number of dorsalized embryos is dose-dependent, increasing 
with the concentration of mRNA injected. Co-injection of both hs3st3s results in a 
dorsalized phenotype in nearly 100% of injected embryos.  
During dorsoventral patterning, BMP signaling promotes the development of 
ventral structures,[110] while Fgf inhibits BMP activity on the dorsal side of the embryo, 
thereby allowing for the development of dorsal structures [111]. An excess of BMP 
signaling favors development of ventral structures, while an excess of Fgf signaling allows 
for the development of dorsal structures at the expense of ventral structures. Thus, the fact 
that hs3st3 mRNA induces dorsalization indicates a role for 3-O-sulfation in positively 
regulating Fgf signaling. 
Figure 3.2.8: Overexpression of hs3st3 mRNA causes dorsalization. (A-C) Examples of normal, 
moderately dorsalized, and highly dorsalized embryos. (D) Graph shows the degree of dorsalization in 
injected embryos. Embryos were injected with either 450pg or 600pg of each hs3st3 mRNA, or co-injected 
with both hs3st3 mRNAs (WT n=23, 3b1a(450pg) n=20, 3b1b(450pg) n=21, 3b1a(600pg) n=52, 
3b1b(600pg) n=23, 3b1a(600pg)+3b1b(600pg) n=19). 
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Both our morpholino-knockdown and mRNA overexpression experiments indicate 
a role for Hs3st3s in Fgf signaling, which would be consistent with previously published 
research on the role of 3-O-sulfation. However, morpholinos are known to have a number 
of off-target effects that can create false phenotypes. This is particularly problematic for 
the phenotype we observe in hs3st3b1a morphants, as we have previously found that 
reduced pea3 expression and increased spacing between neuromasts can be the result of 
off-target effects.  Therefore, we sought to confirm our results using mutants. Targeted 
mutations in the flexible SPLAG domain of hs3st3b1a and hs3st3b1b were induced using 
the CRISPR/Cas9 system.  
 
Hs3st3b1a/hs3st3b1b mutants have fewer neuromasts than wild-types.  
Single mutants in hs3st3b1a and hs3st3b1b appear to have no abnormal phenotype, 
exhibiting a normal number of neuromasts. However, hs3st3b1a/hs3st3b1b double mutants 
have fewer neuromasts than wild-type embryos (Figure 3.2.9A-C). The decrease in the 
number of neuromasts is primarily due to the delay in deposition of L2, and a somewhat 
smaller delay in the deposition of L4 (Figure 3.2.9D). The increased spacing between L1-
L2 and L3-L4 causes all subsequent neuromasts to be deposited significantly later along 
the migration path than they are in wild-type embryos (Figure 3.2.9E). This phenotype 
reflects the morphant phenotype, where we observe a similar increase in interneuromast 
spacing and decrease in neuromast number. 
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The decrease in the number of neuromasts observed in hs3st mutants may correlate 
with compromised Fgf signaling and protoneuromast formation. However, experiments to 
test this hypothesis are still in progress, as these mutants have a low success rate in 
producing fertilized eggs. 
 
3.3 Discussion  
Morphogenesis of the zebrafish lateral line is critically dependent on a coordinated 
signaling network controlled by Wnt and Fgf. This system regulates collective cell 
migration and protoneuromast formation, and disturbances to the network can interfere 
with one or both of these processes. Thus, Wnt and Fgf signaling must be carefully 
controlled, but the regulatory mechanisms responsible for coordinating the integration of 
this network are not fully understood. One signaling regulation mechanism that has not 
been thoroughly explored is the role of HSPGs. HSPGs are ubiquitously expressed and can 
regulate a wide variety of distinct signaling pathways, due to their highly variable structure. 
Figure 3.2.9: Hs3st3b1a/hs3st3b1b double mutants have fewer neuromasts than WT. (A-C) WT 
embryos typically have 6 neuromasts, while hs3st3 mutants have five (WT n=20, Δhs3st3b1a/Δhs3st3b1b 
n=24). (D) The first pair of neuromasts (L1 and L2) and the third pair (L3 and L4) have spaced further apart 
from each other in mutants, than the corresponding neuromasts in WT. (E) The increased spacing between 
some pairs of neuromasts results in a significant delay in the deposition of every neuromast after L1 along 
the path of migration. *p < 0.01. Bars represent mean ± SEM. 
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Variations in this structure allow HSPGs to specifically target a diverse set of ligands. 3-
O-sulfation is a particular component of this structure, a rare modification made to the 
heparan sulfate chain just prior to the completion of biosynthesis. Although this sulfation 
event is rare, some signaling ligands are known to require 3-O-sulfated sites in their HSPG 
binding interaction. Two of the eight enzymes that perform this type of sulfation in 
zebrafish are specifically expressed in the PLLP. We began this study with the intent of 
understanding how these two genes are regulated and the functional significance of 3-O-
sulfation in lateral line signaling and morphogenesis. 
We have shown that these two Hs3st3 enzymes are integrated into the signaling 
pathways that pattern the PLLP. Our results suggest that Wnt signaling activates both 
hs3st3b1a and hs3st3b1b expression, while Fgf signaling is a co-activator for hs3st3b1b. 
The loss of Hs3st3s in morphants and mutants alters neuromast deposition pattern, an Fgf-
directed activity, and morphants exhibit decreased Fgf signaling output. Thus, although 
they are expressed in the leading domain, 3-O-sulfated HSPGs regulate the activity of Fgf 
signaling in the trailing domain. 
While a previous study showed tissue-specific expression of Hs3st3s in the PLLP 
[62], we have further defined the expression of hs3st3b1a and hs3st3b1b. Expression of 
both enzymes is polarized to the leading domain from the start of their expression. Their 
respective domains recede as migration progresses, although hs3st3b1a recedes slightly 
faster than hs3st3b1b. This pattern of expression mirrors that of the Wnt target lef1, which 
is also expressed in the leading domain and also becomes progressively more restricted to 
the leading cells. The similarity between the expression patterns of lef1 and the hs3st3s 
suggested that transcription of these two genes might be activated by Wnt signaling. Our 
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results are consistent with this hypothesis, as activation and repression of Wnt signaling 
correlate with increased and decreased hs3st3 expression, respectively. Expression of both 
hs3st3s remains excluded from the most trailing cells, even when Wnt induces signaling 
activity throughout the whole of the PLLP. We thought that Fgf signaling might be 
responsible for repressing hs3st3 in trailing cells, and so artificially suppressed Fgf activity. 
However, our results show that Fgf has no role in regulating hs3st3b1a, while Fgf and Wnt 
are co-activators of hs3st3b1b. 
To investigate the function of hs3st3s, we initially used morpholinos to knock down 
the function of these genes. These experiments revealed a decrease in the number of 
protoneuromasts forming within the PLLP, and a subsequent change in the neuromast 
deposition pattern. As Fgf signaling governs protoneuromast formation, these results 
indicated a role for 3-O-sulfated HSPGs in facilitating Fgf signaling, which is supported 
by reduced Fgf signaling output in morphants. However, morpholinos have a number of 
off-target effects, including apoptosis, a phenomenon we did observe in these morphants. 
We therefore sought to confirm a role for hs3st3s in Fgf signaling using mutants generated 
by CRISPR/Cas9. Hs3st3b1a/Hs3st3b1b double mutants recapitulate the morphant 
phenotype of fewer deposited neuromasts, hinting that these 3-O-sulfated HSPGs are 
indeed important for Fgf-mediated protoneuromasts formation. Unfortunately, we have not 
yet had the chance to further explore any defects in Fgf signaling exhibited by these 
mutants, as they have extremely low mating success. 
 Overexpression experiments for hs3st3b1a and hs3st3b1b resulted in dorsalization 
of the embryo. Although further experiments are necessary to confirm that this effect is 
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due to ectopic activation of Fgf signaling, this result is consistent with our model that 
Hs3st3s support Fgf signaling in the cells of the PLLP. 
 A handful of ligands have been identified that specifically bind to 3-O-sulfated 
HSPGs. One factor that determines ligand binding is the type of 3-O-sulfation, for the eight 
enzymes that perform this modification fall into two subgroups, each of which 
preferentially sulfate different substrates, ultimately producing unique 3-O-sulfation 
patterns. The 3-O-sulfotransferases that generate Hs3st1-like, or AT-type, activity produce 
a pattern that binds antithrombin (AT) [140], among other ligands. The other group of 3-
O-sulfotransferases perform Hs3st3-like, or gD-type, activity, producing a product capable 
of binding a separate group of ligands, including glycoprotein D (gD), a component of the 
viral envelope of herpes simplex virus (HSV) [132]. Hs3st3b1a and Hs3st3b1b fall into the 
latter category. One known function of Hs3st3-like activity is particularly interesting in the 
framework of our study. In the KIT+ epithelial progenitor cells of mouse fetal salivary 
glands, 3-O-sulfated HSPGs (3-O-HS) stabilize the binding of Fgf10 to FgfR2b, and 
promote Fgf-induced progenitor expansion during development of the salivary glands [90]. 
In this context, Hs3st3-generated 3-O-HS binds FgfR2b, and are involved in a positive 
feedback loop in which 3-O-HS/FgfR2b/Fgf10 signaling enhances the expression of 3-O-
HS. The loss of 3-O-HS reduces Fgf10/FgfR2b-dependent growth, but the introduction of 
3-O-HS rescues this phenotype. This established function of Hs3st3-type 3-O-sulfation is 
consistent with our hypothesis that the enzymatic activity of Hs3st3b1a and Hs3st3b1b has 
a downstream impact on Fgf signaling. 
 Within the migrating PLLP, Fgf has several known functions. First, Fgf is 
responsible for directing protoneuromast formation by promoting the epithelialization of 
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cells and inducing the apical constriction that generates rosettes [9, 10]. Second, Fgf 
signaling initiates center-biased atoh1a expression in the protoneuromasts, helping to 
establish the central cell of each rosette as a sensory hair cell progenitor [9, 27]. Finally, 
Fgf released by the leading cells acts as a migrational cue for trailing cells, which migrate 
and follow the leader cells in response to that cue [26]. Our results indicate that Hs3st3s 
influence the first of these Fgf-mediated processes, assisting in the formation of 
protoneuromasts. We also find that Hs3st3s do not regulate Fgf-mediated cell migration, 
as PLLP migration appears to be unchanged in morphants. Perhaps 3-O-sulfated HSPGs 
are only involved in limited functions of Fgf signaling due to the fact that this is just one 
type of modification on the heparan sulfate chain, and a rare one at that. Hence, we might 
expect the influence of Hs3st3s on signaling to be subtle, as opposed to the more wide-
ranging effects of more common HSPG characteristics. 
Since Hs3st3s are not themselves HSPGS, but enzymes involved in the biosynthesis 
of heparan sulfate chains, there must be some HSPG substrate also synthesized in leading 
cells on which Hs3st3’s perform 3-O-sulfation. There are several HSPGs that could fill this 
substrate role, and future work could identify Hs3st3 target(s) to more completely define 
how HSPGs regulate PLLP signaling. Two candidates are Sdc3 and Glypican1b, which are 
both present in leading cells [39].  
Despite their presence in the leading cells of the PLLP, our results indicated a role 
for these enzymes in promoting Fgf signaling, which is typically active in the trailing 
domain. However, the two Fgf ligands which activate Fgf signaling in those trailing cells, 
Fgf3 and Fgf10, are actually produced by leading cells and then delivered to trailing cells. 
This suggests the possibility that 3-O-sulfation is somehow involved in the effective 
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maturation and/or delivery of Fgf signals to trailing cells. Recent work in our lab indicates 
that some Fgf ligand delivery occurs via filopodia-like structures that extend from leading 
cells and deposit vesicles which are then taken up by trailing cells. The disparate locations 
of hs3st3 expression and Fgf signaling activity suggests that 3-O-sulfated HSPGs might be 
involved in this delivery system. HSPGs can facilitate cargo delivery between cells [145]; 
In fact, HSV hijacks this cargo delivery system in order to bind and invade target cells, and 
its mechanism of cell entry requires Hs3st3-modified HS [141]. HSPGs can also transport 
cargo along filopodia, a process exemplified by a phenomenon known as viral surfing, in 
which HSV virions exploit the cargo transport mechanism to facilitate infection [146]. It 
is possible that HSPGs have a parallel mechanism in the PLLP, with Fgf-packed vesicles 
as the cargo transported along filopodia and received by the trailing cells. If HSPGs do 
function in the delivery of Fgf signals via filopodia-deposited vesicles, given their 
expression patterns, it seems likely that Hs3st3b1a and Hs3st3b1b are important for the 
delivery of the ligand. Further study is required to support this hypothesis; most 
importantly, cell autonomy experiments must be performed, showing that Hs3st3s are 
required in Fgf-source cells in order to activate the FgfR and downstream signaling in 
neighboring cells. 
Our study illustrates how one type of HSPG modification, 3-O-sulfation, is 
integrated into the signaling networks of the PLLP. The two enzymes that perform this 
modification are activated by Wnt signaling in the leading domain, but the HSPGs they 
sulfate appear to regulate Fgf signaling in more trailing cells, where 3-O-sulfated HSPGs 
regulate protoneuromast formation. These findings contribute to our understanding of how 
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the PLL develops, and identify a new function for a rare and understudied HSPG 
modification. 
 
3.4 Appendix  
One movie of PLLP migration made by time-lapse imaging is referenced in this 
chapter. The full-length movie, the title of which is listed below, is available in the 
supplemental files for this dissertation.  
1) Supplemental Movie 4 – WT and 3b1aMO PLLP migration.avi  
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Chapter 4: Concluding remarks and future directions 
The polarized system of Wnt and Fgf signaling in the cells of the migrating 
primordium governs morphogenesis of the zebrafish lateral line. Wnt maintains a relatively 
mesenchymal population of cells in the leading domain, while Fgf signaling organizes cells 
into epithelial rosettes in the trailing domain and induces migration of those trailing cells. 
The interplay between the Wnt and Fgf systems is a critical determinant of protoneuromast 
formation, neuromast deposition, and collective cell migration. However, the mechanisms 
that regulate these two interconnected networks are not fully understood. As HSPGs are 
widespread regulators of many intercellular signaling pathways, and are almost universally 
distributed in animal tissues, this class of molecules make ideal candidates for regulation 
of signaling within the PLLP. I began the work presented in this dissertation knowing that 
two classes of HSPG-related proteins are specifically expressed within the cells of the 
PLLP, but their functions had not been identified. The first was Sdc4, a type of HSPG core 
protein that is embedded in the cell membrane. The second class consisted of two 3-O-
sulfotransferases, Hs3st3b1a and Hs3st3b1b, that both generate a rare, but sometimes 
critical, modification on heparan sulfate chains. 
The work presented in this dissertation investigated particular functions of HSPGs 
in the development of the zebrafish lateral line. Previous research established the general 
importance of HSPGs in Fgf signaling during PLL development [39]. Our research has 
more specifically defined the functions of Sdc4 and 3-O-sulfated HSPGs and their roles in 
mediating protoneuromasts formation and cell migration via Fgf signaling. 
My analysis of the expression patterns of Sdc4 and Hs3st3s revealed that these two 
proteins occupy distinct domains within the PLLP (Figure 4.1). Sdc4 is expressed in the 
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most trailing cells, while hs3st3s are expressed in the leading domain. Wnt and Fgf 
signaling both regulate the expression of these HSPG-related genes. In the case of sdc4, 
Wnt and Fgf signaling both repress its expression, thereby restricting it to the most trailing 
cells, where these signaling networks are less active or not active at all. Meanwhile, Wnt 
activates expression of both hs3st3b1a and hs3st3b1b in leading cells, and Fgf signaling is 
a co-activator of hs3st3b1b. 
Although these proteins occupy disparate domains, they have complementary roles 
in the regulation of Fgf signaling and its downstream functions. Fgf ligands are produced 
by leading cells, where their transcription is dependent on Wnt activity. Since Wnt also 
represses FgfR, Fgf ligands establish robust Fgf signaling centers in the trailing domain, 
where they direct rosettogenesis, sensory hair cell specification, and trailing cell migration. 
Within this Fgf signaling framework, I have identified specific roles for Sdc4 and Hs3sts. 
Hs3st3s are co-expressed in the leading cells that also produce fgf3 and fgf10, and I 
hypothesize that they act to ensure delivery of these two ligands to their receptors on 
Figure 4.1: Schematic for how Sdc4 and Hs3sts regulate signaling within the primordium. Wnt 
signaling (yellow) activates expression of two hs3st isoforms and two Fgf ligands in the leading domain. 
These Hs3sts modify HS chains on unidentified HSPG(s). These 3-O-sulfated HSPGs may play a role in the 
delivery of Fgf3 and Fgf10 ligands from leading cells to trailing cells. Meanwhile, in the trailing domain, Fgf 
signaling (light green) is focused in developing protoneuromasts, promoting protoneuromast formation and 
collective cell migration. Expression of sdc4 is promoted by an unknown factor and repressed by both Fgf 
and Wnt signaling. Sdc4 is involved in reception of the Fgf signal in trailing cells. Sdc4 and Hs3sts are 
therefore on opposite ends of the Fgf signaling pathway, and promote the downstream Fgf-mediated 
processes of neuromast formation and collective cell migration. 
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trailing cells. On the trailing cells, the receiving end of Fgf signaling, Sdc4 promotes Fgf 
signaling in response to those Fgf ligands. Based on the results of experiments utilizing 
both mutants and morphants for these genes, I find that both Hs3st3 and Sdc4 promote 
protoneuromast formation, and Sdc4 has an additional role in cell migration. Thus, Wnt-
activated Hs3st3s are another way in which the leading cells regulate the Fgf signaling 
network that patterns the trailing cells, while Sdc4 provides a mechanism by which Fgf 
signaling can attenuate or facilitate its own function. 
The findings presented here are consistent with known functions of Hs3st3-
modified HSPGs and Sdc4, as presented in the literature. 3-O-sulfated HSPGs have been 
shown to specifically promote Fgf signaling and its downstream effects. The role of Sdc4 
in Fgf signaling is well established, as it can act as both a co-receptor to FgfR and as an 
independent receptor for Fgf ligands. 
Future studies will focus on several aspects that could not be fully explored in the 
context of this dissertation. One particularly interesting line of study is the role of Sdc4 in 
deposited neuromasts. Although we identified notable expression of sdc4 in deposited 
neuromasts, its function(s) there remain unknown. There are several aspects of hair cell 
formation and maintenance in which Sdc4 could play a role. If Sdc4 is involved in Fgf 
signaling in deposited neuromasts, then it may help determine cell fate in the support cells 
that surround the central hair cells. Fgf signaling in these peripheral cells helps ensure their 
fate as support cells and prevents them from adopting a hair cell fate [27].  
It would also be worthwhile to investigate whether Sdc4 is involved in the 
regeneration of hair cells. While the hair cells of the zebrafish PLL and the hair cells of the 
mammalian inner ear are functionally similar, zebrafish hair cells can regenerate and 
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mammalian hair cells cannot (reviewed in [122]). Notch and Wnt signaling are known to 
direct the regeneration of PLL hair cells, and there are some studies that suggests Fgf 
signaling could be involved in this regeneration process as well [27, 122-125]. If Sdc4 
regulates any of these three pathways in the neuromasts, it is possible that it is also a 
regulator of hair cell regeneration. 
One final aspect of hair cell development to which Sdc4 may contribute is the 
planar cell polarity pathway that orients hair cells. The orientation of a hair cell determines 
which water current direction it is capable of detecting. Mature neuromasts have a number 
of hair cells at their center, and all of the hair cells within a neuromast will align themselves 
in parallel but opposing directions, with each pair of hair cells oriented in opposite 
directions. The orientation of these hair cells is determined by the trajectory of PLLP 
migration, as hair cells align along the migration axis [147]. Planar cell polarity (PCP) 
signaling underlies this process of hair cell orientation [148]. PCP signaling is dependent 
on a group of signaling proteins that included the Wnt receptor Frizzled (Fzd), Fzd’s 
cytosolic target Disheveled (Dvl), and another membrane receptor called Vangl2 (reviewed 
in [149]). Previous studies have shown that Sdc4 is actually required for PCP signaling in 
other developmental contexts. During convergent extension in Xenopus, Sdc4 binds to Dvl 
and is required for Fzd-mediated PCP signaling [78]. Furthermore, Sdc4 and Vangl2 
interact genetically and regulate neural tube closure via PCP signaling [150]. Perhaps Sdc4 
plays a similar role in PCP-directed sensory hair cell orientation.	
In the future, we would also like to pursue more direct studies of 3-O-sulfated 
HSPGs and Sdc4 on opposite ends of the delivery mechanism that transports Fgf ligands 
from leading cells to trailing cells may provide exciting insights into how signals can travel 
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between cells, outside the traditional mechanism of ligand diffusion.  Based on recent 
studies performed in our lab, we know that leading cells extend long filopodia-like 
processes towards trailing cells. These processes deposit membrane-bound vesicles that are 
then taken up by trailing cells, where they are rapidly transported from the basal surface to 
the apical surface. We hypothesize that these vesicles contain Fgf signaling ligands, and 
that this is a mechanism by which leading cells signal trailing cells via the Fgf signaling 
pathway. We also have evidence that HSPGs are involved in this vesicle-delivery system, 
as the loss of HS chain sulfation (and therefore the crippling of HSPG function) ultimately 
causes a loss of these filopodia-like processes and the vesicles they deposit. HSPGs are 
known to facilitate cargo delivery between cells [145], and we posit that 3-O-sulfated 
HSPGs and Sdc4 could be involved in the delivery of these vesicles. Herpes Simplex Virus 
(HSV) is known to hijack this cargo delivery system in order to bind and invade target cells 
– and this mechanism of cell infection requires Hs3st3-modified HS and Sdc [141, 151]. 
HSPGs can also transport cargo along filopodia, a process exemplified by a phenomenon 
known as viral surfing, in which HSV virions exploit the cargo transport mechanism to 
facilitate infection [146]. We think that Sdc4 and Hs3st3s may have a parallel function in 
the PLLP, enabling the transport of Fgf-packed vesicles along PLLP filopodia, deposition 
of those vesicles, vesicle uptake by trailing cells, and/or response to the cargo contained 
within those vesicles.  
In order to have any impact on signaling, Hs3st3s must perform 3-O-sulfation on 
an HSPG core protein. There are at least five core proteins expressed in the cells of the 
primordium, but not all are expressed in the leading cells where Hs3st3s are available to 
modify the HS chains. The most attractive candidates for 3-O-sulfation are Gpc1a, 
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expressed in the very most leading cells, and Sdc3, expressed throughout the primordium 
[39]. Future studies will specifically confirm which HSPG core proteins are modified by 
Hs3st3s. 
Experiments described in this thesis using mutants, morphants, and gene expression 
studies have provided us with clues as to the roles of specific HSPGs and HS chain 
modifications in regulating Wnt and Fgf signaling. I hope this work will help us better 
understand morphogenesis of the PLL and the more general principles underlying HSPG 
mediation of intercellular signaling.  
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Chapter 5: Materials and Methods 
5.1 Solutions 
Hybridization buffer: 50% Formamide (Ambion), 5x SSC, ph 7.0 (Quality Biological), 500 
µg/mL yeast tRNA (Sigma-Aldrich), 50µg/mL Heparin (Sigma-Aldrich), 0.1% Tween 20 
(Fisher) in sterile H2O. Stored at -20°C. 
 
50% Formamide/2x SSCT: 50% Formamide (Ambion), 2x SSC (Quality Biological), 0.1% 
Tween 20 (Fisher) in sterile H2O. Stored at RT. 
 
2x SSCT: 2x SSC (Quality Biological), 0.1% Tween 20 (Fisher) in sterile H2O. Stored at 
RT. 
 
0.2x SSCT: 0.2x SSC (Quality Biological), 0.1% Tween 20 (Fisher) in sterile H2O. Stored 
at RT. 
 
Blocking solution: 1% blocking reagent (Roche) in PBST. Stored at 4°C. 
 
NTMT: 100mM Tris, pH 9.5, 50mM MgCl2 (Quality Biological), 100mM NaCl (Quality 
Biological), 0.1% Tween 20 (Fisher). 
 




Genomic digestion buffer: 10mM Tris, ph 8.0 (Quality Biological), 10mM EDTA (Quality 
Biological), 200mM NaCl (Quality Biological), 0.5% SDS (Quality Biological), 200µg/mL 
proteinase K (Abcam). 
 
5.2 Zebrafish  
Zebrafish were maintained under standard conditions and staged according to 
Kimmel et al. (1995) [152]. The tg[cldnb:lynGFP] transgenic strain was described 
previously [20]. 
 
5.3 CRISPR mutants and genotyping 
 Mutant lines were generating using the CRISPR/Cas9 system.[114] CRISPR 
targets were identified using CHOPCHOP (https://chopchop.rc.fas.harvard.edu/), which 
also designed genotyping primers. gRNA templates were generated as previously 
described [153]. Briefly, a targeting oligo (T7 promoter, 20-nucleotide target sequence and 
a 20-nucleotide sequence that overlapped to a generic gRNA template) was annealed with 
an 80-nucleotide chimeric gRNA core sequence. The annealed oligos were then filled in 
using PfuUltra II Fusion DNA Polymerase (Agilent) under the following conditions: 98°C 
for 2 minutes; 50°C for 10 minutes, 72°C for 10 minutes. 2µL of gRNA template was then 
used to transcribe gRNA by in vitro transcription using the HiScribe T7 Yield RNA 
Synthesis kit (New England BioLabs). To induce target mutations, embryos from the 
tg[cldnb:lynGFP] line were co-injected with 250pg of gRNA and 250ng of Cas9 protein 
(PNA Bio). Indels were detected via PCR and confirmed by sequencing. Table 5.7.1 lists 
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oligos used for gRNA synthesis. All oligos and PCR primers were obtained from Eurofins 
MWG Operon. 
Table 5.3.1: gRNA oligos 
Target 
gene 














 For genotyping, DNA was extracted from embryos or fin clips through digestion in 
genomic digestion buffer at 55°C overnight. DNA digestion was diluted 1:25 prior to PCR. 
Table 5.7.2 lists the primers used for genotyping. PCR samples were genotyped using an 
Applied Biosystems 3130xl Genetic Analyzer. 




sdc4 Forward 5’-TGTAAAACGACGGCCAGTTGTGTCTCTCAGCTGTGACCTT-3’ 
Reverse 5’-GTGTCTTATCCTCATCGTCAGTCTGGTTT-3’ 
hs3st3b1a Forward 5’-TGTAAAACGACGGCCAGTAGGGACCTGCTAAACAACGA-3’ 
Reverse 5’-GTGTCTTTTATTATCGCTTGGGGCAAC-3’ 
hs3st3b1b Forward 5’-TGTAAAACGACGGCCAGTATGCTGCTCCTCTGGGTCTA-3’ 
Reverse 5’-GTGTCTTGTCTGGACAGGAGCTTGGAC-3’ 
 
5.4 Morpholinos and chemical inhibitors 
 Tables 5.4.1 and 5.4.2 list the morpholino and chemical inhibitors used.  
 
 All morpholinos were acquired from Gene-Tools, LLC, diluted in sterile H2O to 
20µg/µl stock concentration and stored at RT. All morpholinos were co-injected with the 
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p53 morpholino. Unless otherwise stated, one-cell stage embryos were injected with the 
working concentration listed. 
Table 5.4.1: Morpholinos 
Target Blocking Type Sequence Effective 
Concentration 
p53 Translation 5’-GCGCCATTGCTTTGCAAGAATTG-3’ 1.5 ng/nl 
sdc4 Translation 5’-CGGACAACTTTATTCACTCGGGCTA-3’ 4 ng/nl 
fgf10 Translation 5’-GCTTTACTCACTGTACGGATCGTCC-3’ 4 ng/nl 
sdc3 Translation 5’-GTGCTGGGTGTGAATAAACCCTTCT-3’ 4 ng/nl 
cxcl12a Translation 5’-TTGAGATCCATGTTTGCAGTGTGAA-3’ 4ng/nl 
hs3st3b1a Translation 5’-ACACCCACAGCGAGAGCATGATGCA-3’ 6ng/nl 
hs3st3b1b Translation 5’-GGTGACAGAACAGGCTATATTCCAT-3’ 6ng/nl 
hs3st3b1a Splice 5’-TGTGTGGATAAAAAAACGTACCTGT-3’ 2ng/nl 
hs3st3b1b Splice 5’-ATTAGTAGCATTCGTACCTGTACCA-3’ 6ng/nl 
 
 Chemical inhibitors were diluted in DMSO, except for NaClO3, which was diluted 
in egg water. Chemical treatment lasted 5-6 hours prior to fixation of embryos in 4% PFA. 
Table 5.4.2: Chemical inhibitors 
Inhibitor Concentration  Inhibition Target Source 
DMSO 5µM none - control American 
Bioanalytical 
IWR-1 10-30µM TNKS1/PARP5a, TNKS2/PARP5b (suppresses Wnt) Calbiochem 
BIO 5µM GSK-3a/b (activates Wnt) Calbiochem 
NaClO3 200mM formation of 3′-phosphoadenosine 5′-phosphosulfate 
(PAPS) (suppresses HSPG sulfation) 
Sigma-Aldrich 
K02288 30µM Type I BMP receptors Tocris 
SU5402 10µM VEGF and Fgf receptors Tocris 
 
5.5 In situ hybridization  
In situ probes and hybridization protocol 
 Clones containing the pCS2+ vector with the full open reading frame of sdc4, 
hs3st3b1a, hs3st3b1b, were obtained from GenScript. In addition to probes generated from 
these clones, the lef1 and pea3 probes were also used [27]. RNA probes were synthesized 
using a DIG labeling kit (Roche). In situ hybrization was performed on embryos fixed in 
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4% PFA overnight at 4°C and stored in 100% methanol at -20°C. They were rehydrated in 
a descending series of methanol to PBST, permeabilized in 10 µg/ml proteinase K, and 
hybridized with DIG-labeled antisense RNA probes at 65°C overnight. Embryos were 
washed sequentially in 50% formamide/2x SSCT, 2x SSCT and 0.2x SSCT at 65°C, 
blocked for 1 hr in blocking solution, and then incubated with anti-DIG-AP antibody in 
blocking solution for 2 hr at RT. After washing with PBST and then NTMT staining buffer 
embryos were incubated in NTMT staining buffer with BCIP/NBT (Roche). To stop the 
color reaction, embryos were washed with PBST and then fixed in 4% PFA. To clearly 
delineate the boundaries of the PLLP in DIC images, embryos were stained after in situ 
with anti-GFP antibody (Abcam). For flat mounting, the yolk was dissected away and 
embryos were mounted for imaging in 100% glycerol.  
 
In situ image analysis 
 All images were analyzed using ImageJ. For domain length quantification, 
expression domain lengths were measured and then normalized by comparison to PLLP 
length. Similarly, distance from the leading edge was measured and also normalized to 
PLLP length. 
 For quantification of expression intensity, color images were converted to 8-bit 
grayscale and inverted from positive to negative. The average gray value of all of the pixels 
within the PLLP was measured, as was the average gray value of the pixels in the 
background. The ratio of PLLP pixel gray value to background pixel gray value was taken 
and averaged for each experimental group. 
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5.6 Morpholino and mRNA microinjection  
 Clones containing the pCS2+ vector with the full open reading frame of sdc4, 
hs3st3b1a, hs3st3b1b, were obtained from GenScript. Plasmids were linearized using 
FastDigest NotI (ThermoFisher) and mRNA was transcribed using the mMessage 
mMachine SP6 RNA transcription kit (Ambion). 
 For microinjection, morpholinos were diluted to concentrations between 1.5-
6ng/nl, depending on the efficacy of the morpholino, in DEPC-H2O and phenol red dye. 
Similarly, mRNA was diluted to concentrations between 10-600pg in Ultra Pure Water and 
RNAse-free phenol red. Needles were loaded into a pneumatic injection rig and calibrated 
to inject 1nl of injection mix. One-cell stage embryos were aligned on a grooved agarose 
mold and injected prior to the first cleavage. 
 
5.7 Microscopy  
 Still images of embryos were captured on a Leica MZ16F fluorescent microscope. 
In situ images were taken on Zeiss LSM 510 META confocal microscope. For time-lapse 
imaging, embryos were anesthetized at 26-28hpf in 600 µM MS-222 (Sigma) and mounted 
in 0.8% low melting temperature agarose (NuSieve GTG) and placed in a solution of egg 
water with 600 µM tricaine or imaging. On a Leica SP5 confocal microscope, 25 z-stack 
images were acquired at 5-minute intervals for between 5 and 24 hours. Time-lapse images 
were compressed and stitched into movies in ImageJ.  
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5.8 Statistical analysis  
 Unpaired, two-tailed t-tests were used to determine statistical significance. p values 
less than 0.05 were considered statistically significant. All statistical analysis was 
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